https://novapharmanews.com/eu/articles/cynata-therapeutics-asx-cyp-european-regulatory-progress-cyp-001 2026-06-03T11:08:19.574Z daily 0.7 https://novapharmanews.com/eu/articles/ema-united-for-health-worldpride-2026 2026-06-03T10:58:55.523Z daily 0.7 https://novapharmanews.com/eu/articles/cinnagen-zandoriah-eu-approval-osteoporosis 2026-06-03T09:58:45.191Z daily 0.7 https://novapharmanews.com/us/articles/fda-approves-oral-nilotinib-tablets-ph-cml 2026-06-03T08:59:40.318Z daily 0.7 https://novapharmanews.com/us/articles/fda-approves-xocova-pharmaceutical-industry-mergers-licensing 2026-06-03T10:08:33.371Z daily 0.7 https://novapharmanews.com/us/articles/cencora-kite-agreement-cgt-commercialization-shift 2026-06-03T10:49:30.076Z daily 0.7 https://novapharmanews.com/us/articles/bio-international-convention-2026-preview 2026-06-03T10:36:58.177Z daily 0.7 https://novapharmanews.com/us/articles/fda-grants-priority-review-giredestrant-er-her2-breast-cancer 2026-06-03T09:03:02.261Z daily 0.7 https://novapharmanews.com/us/articles/fda-rudderless-clinical-trials-adrift 2026-06-03T09:58:05.139Z daily 0.7 https://novapharmanews.com/us/articles/fda-approves-orally-disintegrating-nilotinib-cavhanza-cml 2026-06-03T08:56:36.805Z daily 0.7 https://novapharmanews.com/us/articles/tenaya-therapeutics-to-unveil-tn-201-gene-therapy-hcm-trial-data-june-3-2026 2026-06-03T08:57:21.254Z daily 0.7 https://novapharmanews.com/us/articles/biosimilars-reduce-specialty-drug-spend 2026-06-03T08:57:04.560Z daily 0.7 https://novapharmanews.com/us/articles/alx-oncology-2026-jefferies-conference-oncology-presentation 2026-06-03T08:17:58.794Z daily 0.7 https://novapharmanews.com/us/articles/legend-biotech-in-vivo-car-t-stock-surge-analysis 2026-06-03T08:57:49.642Z daily 0.7 https://novapharmanews.com/eu/articles/sfee-greek-patient-access-new-medicines-delays 2026-06-03T08:59:34.989Z daily 0.7 https://novapharmanews.com/eu/articles/medscape-education-ai-hematology-eha-2026 2026-06-03T08:57:57.829Z daily 0.7 https://novapharmanews.com/us/articles/advancing-bladder-cancer-care-education-awareness 2026-06-03T04:53:14.489Z daily 0.7 https://novapharmanews.com/us/articles/fulcrum-explores-sale-fda-sickle-cell-drug-setback 2026-06-03T08:59:38.012Z daily 0.7 https://novapharmanews.com/us/articles/eu-roadmap-reduce-animal-testing-pharma 2026-06-03T04:39:56.201Z daily 0.7 https://novapharmanews.com/us/articles/asco-26-bispecifics-adcs-ras-revolution-oncology 2026-06-03T08:57:55.001Z daily 0.7 https://novapharmanews.com/us/articles/celcuity-gedatolisib-trial-misses-expectations-breast-cancer 2026-06-03T08:59:48.464Z daily 0.7 https://novapharmanews.com/eu/articles/os-therapies-ost-her2-phase-2b-survival-milestone 2026-06-03T10:05:47.392Z daily 0.7 https://novapharmanews.com/eu/articles/quoin-pharmaceuticals-first-fda-trial-peeling-skin-syndrome-ind-submission 2026-06-03T08:58:11.766Z daily 0.7 https://novapharmanews.com/eu/articles/oxurion-expands-glp-1-peptide-research-services 2026-06-03T04:58:50.560Z daily 0.7 https://novapharmanews.com/eu/articles/asco26-astrazeneca-camizestrant-data-fda-approval 2026-06-03T05:56:52.499Z daily 0.7 https://novapharmanews.com/eu/articles/maat-pharma-q1-2026-business-update-financial-results 2026-06-03T08:18:50.507Z daily 0.7 https://novapharmanews.com/us/articles/sun-pharma-organon-hsr-filing-antitrust-clearance 2026-06-03T04:40:58.014Z daily 0.7 https://novapharmanews.com/us/articles/biopharma-news-approvals-appeals-ai-week-of-june-2026 2026-06-03T08:13:09.951Z daily 0.7 https://novapharmanews.com/us/articles/tissue-tmb-outperforms-blood-tmb-immunotherapy-response 2026-06-03T04:20:40.765Z daily 0.7 https://novapharmanews.com/us/articles/celcuity-gedatolisib-fda-approval-breast-cancer 2026-06-03T08:59:41.200Z daily 0.7 https://novapharmanews.com/us/articles/fda-delays-astrazeneca-camizestrant-after-adcomm-vote 2026-06-03T08:57:59.379Z daily 0.7 https://novapharmanews.com/us/articles/fda-clinical-trial-transparency-enforcement-guide-2026 2026-06-03T08:12:08.602Z daily 0.7 https://novapharmanews.com/us/articles/kazia-therapeutics-appoints-james-levine-cfo 2026-06-03T04:20:46.030Z daily 0.7 https://novapharmanews.com/us/articles/fda-declines-cingulate-adhd-drug-manufacturing-issues 2026-06-03T08:18:47.852Z daily 0.7 https://novapharmanews.com/us/articles/eli-lilly-issues-data-sharing-ultimatum-to-340b-hospitals 2026-06-03T08:14:13.104Z daily 0.7 https://novapharmanews.com/us/articles/radiopharmaceutical-promise-post-pluvicto-competitive-insights 2026-06-03T08:58:10.276Z daily 0.7 https://novapharmanews.com/us/articles/stat-longevity-startup-newlimit-raises-435-million-ahead-of-first-clinical-trial 2026-06-03T08:18:49.238Z daily 0.7 https://novapharmanews.com/apac/articles/minghui-qilu-mhbo88c-asco-2026-data 2026-06-03T08:56:22.905Z daily 0.7 https://novapharmanews.com/eu/articles/naldemedine-china-approval-opioid-induced-constipation 2026-06-03T04:20:58.034Z daily 0.7 https://novapharmanews.com/eu/articles/os-therapies-ost-her2-fda-accelerated-approval-osteosarcoma-asco-data 2026-06-03T10:05:47.680Z daily 0.7 https://novapharmanews.com/eu/articles/enyo-pharma-jeff-george-chairman-growth-phase-3-readiness 2026-06-03T04:21:02.153Z daily 0.7 https://novapharmanews.com/eu/articles/eli-lilly-340b-policy-hospital-networks-pharma-strategy 2026-06-03T04:21:04.122Z daily 0.7 https://novapharmanews.com/eu/articles/karyopharm-selinexor-ruxolitinib-sentry-trial-eha-2026-presentation 2026-06-03T06:04:17.967Z daily 0.7 https://novapharmanews.com/eu/articles/ema-chmp-recommends-oral-wegovy-approval-europe 2026-06-03T04:21:08.036Z daily 0.7 https://novapharmanews.com/us/articles/asco-2026-preview-key-data-trends-cancer-research 2026-06-03T04:21:10.046Z daily 0.7 https://novapharmanews.com/us/articles/experimental-pancreatic-cancer-drug-offers-new-hope-in-major-trial 2026-06-03T10:49:34.582Z daily 0.7 https://novapharmanews.com/us/articles/this-week-in-breast-cancer-camizestrant-delay-bria-imt-data-recurrence-test 2026-06-03T04:21:14.068Z daily 0.7 https://novapharmanews.com/us/articles/vyome-holdings-q1-2026-fda-filings-financial-strength 2026-06-03T04:21:22.325Z daily 0.7 https://novapharmanews.com/us/articles/rallybio-avenzo-agree-oncology-reverse-merger-backed-by-215-million-financing 2026-06-03T06:38:55.791Z daily 0.7 https://novapharmanews.com/us/articles/organon-ogn-to-be-acquired-by-sun-pharma-for-14-00-cash-per-share 2026-06-03T06:38:54.128Z daily 0.7 https://novapharmanews.com/us/articles/top-10-u-s-biopharma-clusters-2026 2026-06-03T08:56:45.287Z daily 0.7 https://novapharmanews.com/us/articles/duchesnay-pharmaceutical-group-growth-five-years-post-acquisition 2026-06-03T08:21:19.717Z daily 0.7 https://novapharmanews.com/us/articles/inventiva-comprehensive-capital-structure-financing-analysis 2026-06-03T06:38:48.035Z daily 0.7 https://novapharmanews.com/us/articles/fda-clears-iovance-il-12-til-trial-valuation-gap-widens 2026-06-03T04:21:28.060Z daily 0.7 https://novapharmanews.com/us/articles/abivax-stock-plummets-cancer-cases-ulcerative-colitis-trial 2026-06-03T04:21:30.066Z daily 0.7 https://novapharmanews.com/us/articles/fda-approves-ensitrelvir-for-post-exposure-prophylaxis-of-covid-19 2026-06-03T08:32:23.334Z daily 0.7 https://novapharmanews.com/us/articles/abivax-falls-as-safety-worries-cloud-landmark-immune-drug-results 2026-06-03T04:21:34.072Z daily 0.7 https://novapharmanews.com/us/articles/fda-issues-draft-guidance-to-help-accelerate-cell-and-gene-therapies-for-patients 2026-06-03T06:38:45.241Z daily 0.7 https://novapharmanews.com/eu/articles/fda-approves-astrazenzas-imfinzi-bcg-combination-nmibc 2026-06-03T04:21:38.070Z daily 0.7 https://novapharmanews.com/eu/articles/asco26-summit-akeso-claim-os-victory-for-ivonescimab-in-pivotal-chinese-study 2026-06-03T08:20:46.865Z daily 0.7 https://novapharmanews.com/eu/articles/medscape-ai-hematology-eha-2026-catalyst 2026-06-03T10:44:51.147Z daily 0.7 https://novapharmanews.com/eu/articles/os-therapies-publishes-ost-her2-osteosarcoma-articles 2026-06-03T04:21:48.020Z daily 0.7 https://novapharmanews.com/eu/articles/ema-celebrates-diversity-and-inclusion-in-science-and-healthcare 2026-06-03T07:00:42.895Z daily 0.7 https://novapharmanews.com/eu/articles/future-of-gmp-reliance-annex-1-ai 2026-06-03T04:21:48.092Z daily 0.7 https://novapharmanews.com/eu/articles/arrowhead-pharmaceuticals-june-2026-events-participation 2026-06-03T04:21:50.089Z daily 0.7 https://novapharmanews.com/eu/articles/biocryst-presents-new-hae-data-orladeyo-navenibart-eaaci-2026 2026-06-03T04:21:52.086Z daily 0.7 https://novapharmanews.com/eu/articles/intellia-therapeutics-to-report-additional-phase-3-haelo-data-for-lonvoguran-ziclumeran-lonvo-z-in-l 2026-06-03T04:21:54.085Z daily 0.7 https://novapharmanews.com/eu/articles/ec-opens-2026-jsc-submission-window 2026-06-03T04:21:56.086Z daily 0.7 https://novapharmanews.com/us/articles/personalized-mrna-cancer-vaccines-melanoma-treatment 2026-06-03T10:38:10.399Z daily 0.7 https://novapharmanews.com/us/articles/healthcare-ai-market-concentration-lifecycle-regulation-entry-barrier 2026-06-03T04:22:01.231Z daily 0.7 https://novapharmanews.com/us/articles/fda-human-factors-guidance-new-submission-category 2026-06-03T04:22:02.275Z daily 0.7 https://novapharmanews.com/us/articles/computer-software-assurance-benefits-pharma 2026-06-03T05:39:43.325Z daily 0.7 https://novapharmanews.com/us/articles/fda-oncology-draft-guidance-reduce-animal-testing 2026-06-03T04:41:05.568Z daily 0.7 https://novapharmanews.com/us/articles/cumberland-pharmaceuticals-nasdaq-cpix-to-divest-marketed-brands-to-apotex-for-100m 2026-06-03T04:22:08.098Z daily 0.7 https://novapharmanews.com/us/articles/regulating-private-equity-in-healthcare-policy-agenda 2026-06-03T11:19:38.184Z daily 0.7 https://novapharmanews.com/us/articles/ohiohealth-fairfield-medical-center-merger-termination 2026-06-03T11:03:35.578Z daily 0.7 https://novapharmanews.com/us/articles/kardigan-ipo-heart-disease-drugs-2026 2026-06-03T07:18:32.194Z daily 0.7 https://novapharmanews.com/us/articles/top-biotech-penny-stocks-2026-watch-list 2026-06-03T04:40:21.352Z daily 0.7 https://novapharmanews.com/us/articles/biotech-movers-moderna-iovance-alhc-smmt-focus 2026-06-03T04:40:49.863Z daily 0.7 https://novapharmanews.com/us/articles/fda-grants-orphan-status-to-oxaliplatin-for-hard-to-treat-pancreatic-cancer 2026-06-03T04:40:41.826Z daily 0.7 https://novapharmanews.com/us/articles/gilead-hepatitis-d-approval-bay-area-rivals 2026-06-03T06:38:46.637Z daily 0.7 https://novapharmanews.com/us/articles/fda-approves-mannkinds-afrezza-pediatric-diabetes 2026-06-03T07:59:10.580Z daily 0.7 https://novapharmanews.com/us/articles/elite-pharmaceuticals-announces-filing-of-abbreviated-new-drug-application-with-the-u-s-food-and-dru 2026-06-03T04:40:11.965Z daily 0.7 https://novapharmanews.com/apac/articles/pulse-of-acc-eugene-braunwald-cardiology-future 2026-06-03T09:03:13.495Z daily 0.7 https://novapharmanews.com/apac/articles/nilesh-shah-illumina-apac-strategy-competitive-benchmark 2026-06-03T09:02:35.992Z daily 0.7 https://novapharmanews.com/apac/articles/medicine-forgot-women-asia-opportunity 2026-06-03T08:48:41.099Z daily 0.7 https://novapharmanews.com/us/articles/abbvie-decnupaz-fda-approval-rare-blood-cancer 2026-06-03T04:22:34.131Z daily 0.7 https://novapharmanews.com/us/articles/eli-lilly-340b-data-mandate-hospitals-claims-discount 2026-06-03T06:38:38.045Z daily 0.7 https://novapharmanews.com/us/articles/inside-makarys-ouster-lilly-triple-g-success 2026-06-03T11:18:24.550Z daily 0.7 https://novapharmanews.com/us/articles/trump-executive-order-childhood-vaccine-schedule-pharma-impact 2026-06-03T11:03:05.440Z daily 0.7 https://novapharmanews.com/us/articles/servier-edgewise-muscular-dystrophy-deal 2026-06-03T04:22:42.521Z daily 0.7 https://novapharmanews.com/eu/articles/her2-biology-next-gen-cancer-treatment 2026-06-03T10:09:59.655Z daily 0.7 https://novapharmanews.com/apac/articles/executive-order-childhood-vaccine-schedule-pharma-impact 2026-06-03T04:51:22.538Z daily 0.7 https://novapharmanews.com/apac/articles/her2-biology-next-generation-cancer-treatment 2026-06-03T04:22:48.153Z daily 0.7 https://novapharmanews.com/apac/articles/shionogi-xocova-fda-covid-post-exposure-prevention 2026-06-03T09:06:08.633Z daily 0.7 https://novapharmanews.com/apac/articles/executive-order-childhood-vaccine-schedule-pharma-implications 2026-06-03T08:18:52.169Z daily 0.7 https://novapharmanews.com/us/articles/asco-2026-cancer-care-barriers-new-treatments 2026-06-03T04:22:54.168Z daily 0.7 https://novapharmanews.com/us/articles/cepi-funds-three-ebola-vaccine-candidates-accelerate-outbreak-response 2026-06-03T10:12:27.185Z daily 0.7 https://novapharmanews.com/us/articles/trumprx-adds-generic-medicines 2026-06-03T10:36:49.787Z daily 0.7 https://novapharmanews.com/us/articles/immunovant-autoimmune-blockbuster-wave-rna-editing 2026-06-03T10:35:16.805Z daily 0.7 https://novapharmanews.com/us/articles/leadership-changes-amgen-zai-lab 2026-06-03T10:29:45.519Z daily 0.7 https://novapharmanews.com/eu/articles/immunitybio-anktiva-fda-decision-date 2026-06-03T10:06:51.358Z daily 0.7 https://novapharmanews.com/us/articles/wave-monthly-dosing-aatd-treatment 2026-06-03T10:02:08.802Z daily 0.7 https://novapharmanews.com/us/articles/retro-biosciences-1-8-billion-fundraising 2026-06-03T09:41:20.937Z daily 0.7 https://novapharmanews.com/us/articles/roche-alecensa-japan-expansion-alk-tumors 2026-06-03T09:13:41.942Z daily 0.7 https://novapharmanews.com/us/articles/surgeon-general-warning-screen-time-children 2026-06-03T08:16:12.699Z daily 0.7 https://novapharmanews.com/eu/articles/ucb-bimzelx-psoriatic-arthritis-skyrizi 2026-06-03T07:31:15.208Z daily 0.7 https://novapharmanews.com/us/articles/eli-lilly-pharma-rd-performance 2026-06-03T06:38:39.604Z daily 0.7 https://novapharmanews.com/apac/articles/cder-leadership-changes-impact-pharma 2026-06-03T06:16:33.043Z daily 0.7 https://novapharmanews.com/us/articles/fda-leadership-vacuum-tracy-beth-hoeg 2026-06-03T04:40:26.709Z daily 0.7 https://novapharmanews.com/us/articles/biogen-investigation-multiple-sclerosis-market-abuse 2026-06-03T04:31:22.955Z daily 0.7 https://novapharmanews.com/us/articles/biogen-alzheimers-data-leadership-changes 2026-06-03T04:23:42.214Z daily 0.7 https://novapharmanews.com/us/articles/candel-prostate-cancer-drug-long-term-data-fda-filing 2026-06-03T04:23:38.209Z daily 0.7 https://novapharmanews.com/us/articles/dcat-week-2024-preview 2026-06-03T04:23:36.211Z daily 0.7 https://novapharmanews.com/apac/articles/ucb-bimzelx-psoriatic-arthritis-win 2026-06-03T04:23:35.949Z daily 0.7 https://novapharmanews.com/us/articles/eli-lilly-acquires-vaccine-developers 2026-06-03T04:23:34.211Z daily 0.7 https://novapharmanews.com/us/articles/lilly-engage-acquisition-non-viral-genetic-medicines 2026-06-03T04:23:32.212Z daily 0.7 https://novapharmanews.com/us/articles/fda-warns-illegal-tobacco-products 2026-06-03T04:23:28.209Z daily 0.7 https://novapharmanews.com/us/articles/supreme-court-medicare-drug-price-negotiation 2026-06-03T04:23:24.856Z daily 0.7 https://novapharmanews.com/eu/articles/eisai-leqembi-sales-forecast-blockbuster-status 2026-06-03T04:23:24.198Z daily 0.7 https://novapharmanews.com/us/articles/bms-hengrui-15b-deal-analysis 2026-06-03T04:23:04.169Z daily 0.7 https://novapharmanews.com/us/articles/white-house-amazon-goodrx-trumprx 2026-06-03T04:23:02.162Z daily 0.7 https://novapharmanews.com/us/articles/fda-misses-electric-shock-ban-deadline-advocates-voice-concerns 2026-06-03T04:23:46.225Z daily 0.7 https://novapharmanews.com/apac/articles/rusan-pharma-pmda-approval-global-credentials 2026-06-03T08:20:51.245Z daily 0.7 https://novapharmanews.com/us/articles/her2-biology-next-gen-cancer-treatment 2026-06-03T07:45:11.298Z daily 0.7 https://novapharmanews.com/us/articles/rallybio-avenzo-reverse-merger-autoimmune-therapeutics 2026-06-03T04:23:52.223Z daily 0.7 https://novapharmanews.com/us/articles/hospitals-unvaccinated-donor-blood-demand 2026-06-03T06:52:30.115Z daily 0.7 https://novapharmanews.com/us/articles/medicare-glp-1-unitedhealthcare-lawsuit-pharma-implications 2026-06-03T04:23:56.221Z daily 0.7 https://novapharmanews.com/us/articles/asco-2026-grief-takes-center-stage-amidst-cancer-data 2026-06-03T04:40:31.724Z daily 0.7 https://novapharmanews.com/us/articles/abivax-obefazimod-ulcerative-colitis-efficacy-safety-concerns 2026-06-03T08:22:32.841Z daily 0.7 https://novapharmanews.com/us/articles/eli-lilly-pharma-rd-rankings 2026-06-03T04:24:02.248Z daily 0.7 https://novapharmanews.com/us/articles/merck-adc-global-trial-results 2026-06-03T04:24:04.234Z daily 0.7 https://novapharmanews.com/us/articles/ucb-bimzelx-skyrizi-psoriatic-arthritis 2026-06-03T05:03:28.837Z daily 0.7 https://novapharmanews.com/us/articles/niowave-radiopharmaceutical-plant-michigan 2026-06-03T04:24:14.477Z daily 0.7 https://novapharmanews.com/us/articles/leadership-changes-fda-implications-pharma 2026-06-03T06:04:39.622Z daily 0.7 https://novapharmanews.com/us/articles/fda-leadership-changes-tracy-beth-hoeg-resignation 2026-06-03T04:24:12.250Z daily 0.7 https://novapharmanews.com/us/articles/how-to-use-openfda-faers-responsibly 2026-06-03T09:32:45.527Z daily 0.7 https://novapharmanews.com/us/articles/summa-health-tech-initiatives-general-catalyst 2026-06-03T11:21:30.564Z daily 0.7 https://novapharmanews.com/eu/articles/about-us-pharmaceutical-innovation 2026-06-03T10:55:01.523Z daily 0.7 https://novapharmanews.com/eu/articles/astrazeneca-imfinzi-imjudo-liver-cancer-breakthrough 2026-06-03T10:50:53.765Z daily 0.7 https://novapharmanews.com/us/articles/diversity-medical-education-diverse-doctors 2026-06-03T09:30:02.728Z daily 0.7 https://novapharmanews.com/us/articles/no-surprises-act-arbitration-rule-provider-disputes 2026-06-03T09:02:06.547Z daily 0.7 https://novapharmanews.com/eu/articles/direct-to-patient-future-pharma-access 2026-06-03T08:03:30.185Z daily 0.7 https://novapharmanews.com/us/articles/servier-acquires-edgewise-muscular-dystrophy-drug 2026-06-03T05:35:53.942Z daily 0.7 https://novapharmanews.com/us/articles/hidden-history-bpc-157-maha-peptide 2026-06-03T04:24:34.284Z daily 0.7 https://novapharmanews.com/us/articles/2026-orphan-drugs-report-navigating-challenges 2026-06-03T04:24:32.271Z daily 0.7 https://novapharmanews.com/apac/articles/merck-phase-3-program-gap 2026-06-03T04:24:24.347Z daily 0.7 https://novapharmanews.com/us/articles/14-new-weight-loss-drugs-regulatory-updates 2026-06-03T10:09:59.195Z daily 0.7 https://novapharmanews.com/us/articles/revolution-medicines-pancreatic-cancer-drug-results 2026-06-03T09:56:42.135Z daily 0.7 https://novapharmanews.com/eu/articles/akeso-ivonescimab-nsclc-pd1-inhibitors 2026-06-03T09:17:19.458Z daily 0.7 https://novapharmanews.com/us/articles/revolutionary-data-paradigm-shift-pancreatic-cancer 2026-06-03T08:53:44.985Z daily 0.7 https://novapharmanews.com/eu/articles/j-j-erleada-prostate-cancer-treatment 2026-06-03T08:39:58.646Z daily 0.7 https://novapharmanews.com/us/articles/ultra-low-doses-cancer-treatment-access 2026-06-03T08:11:57.891Z daily 0.7 https://novapharmanews.com/eu/articles/revolution-medicines-ras-leadership-asco 2026-06-03T07:39:29.271Z daily 0.7 https://novapharmanews.com/us/articles/akeso-summit-drug-lung-cancer-trial 2026-06-03T07:00:07.487Z daily 0.7 https://novapharmanews.com/eu/articles/eli-lilly-retevmo-lung-cancer-outcomes 2026-06-03T05:34:12.117Z daily 0.7 https://novapharmanews.com/us/articles/new-hormone-regimen-prostate-cancer-surgery 2026-06-03T04:24:58.302Z daily 0.7 https://novapharmanews.com/us/articles/ivonescimab-squamous-cell-lung-cancer-survival 2026-06-03T04:24:54.156Z daily 0.7 https://novapharmanews.com/us/articles/revmed-akeso-stat-news-analysis 2026-06-03T04:24:48.286Z daily 0.7 https://novapharmanews.com/apac/articles/glyconex-pmda-approval-gnx1021-phase-i-trial 2026-06-03T10:00:40.110Z daily 0.7 https://novapharmanews.com/eu/articles/os-therapies-acquires-ip-rights-ost-her2 2026-06-03T08:51:31.266Z daily 0.7 https://novapharmanews.com/us/articles/biotech-stocks-fda-decision-june-2026 2026-06-03T04:25:11.690Z daily 0.7 https://novapharmanews.com/eu/articles/ascentage-pharma-olverembatinib-update-asco-2026 2026-06-03T04:25:10.319Z daily 0.7 https://novapharmanews.com/us/articles/cnpv-pilot-program-clinical-trials-insights 2026-06-03T04:25:04.310Z daily 0.7 https://novapharmanews.com/eu/articles/maat-pharma-regulatory-update-maat013-xervyteg-gvhd 2026-06-03T04:25:00.302Z daily 0.7 https://novapharmanews.com/us/articles/bio-2026-preview 2026-06-03T04:25:12.319Z daily 0.7 https://novapharmanews.com/us/articles/bio-2026-event-preview 2026-06-03T09:29:58.770Z daily 0.7 https://novapharmanews.com/us/articles/friday-five-regulatory-updates-pharma 2026-06-03T09:21:59.927Z daily 0.7 https://novapharmanews.com/us/articles/revolution-medicines-pancreatic-cancer-drug-shipping 2026-06-03T08:59:10.993Z daily 0.7 https://novapharmanews.com/us/articles/fda-restructuring-china-competition 2026-06-03T07:47:32.996Z daily 0.7 https://novapharmanews.com/us/articles/replimune-fda-approval-pfizer-china-deal 2026-06-03T06:20:47.392Z daily 0.7 https://novapharmanews.com/us/articles/zydus-lifesciences-fda-priority-review-liver-disease 2026-06-03T05:49:17.640Z daily 0.7 https://novapharmanews.com/eu/articles/actinogen-ema-scientific-advice-alzheimers-program 2026-06-03T05:29:40.549Z daily 0.7 https://novapharmanews.com/eu/articles/global-biosimilar-market-analysis-trends-challenges 2026-06-03T04:27:37.323Z daily 0.7 https://novapharmanews.com/us/articles/biontech-pfizer-bispecifics-data-fda 2026-06-03T04:25:30.461Z daily 0.7 https://novapharmanews.com/us/articles/philips-disney-mri-anxiety 2026-06-03T07:11:06.480Z daily 0.7 https://novapharmanews.com/us/articles/concerns-over-glp-1-microdoses 2026-06-03T05:54:49.971Z daily 0.7 https://novapharmanews.com/us/articles/stat-woman-longevity-competition 2026-06-03T04:25:38.346Z daily 0.7 https://novapharmanews.com/eu/articles/luxembourg-institute-science-technology-europabio 2026-06-03T04:25:32.351Z daily 0.7 https://novapharmanews.com/apac/articles/philips-disney-mri-anxiety 2026-06-03T09:42:55.688Z daily 0.7 https://novapharmanews.com/us/articles/modernizing-patient-support-young-adult-cancer 2026-06-03T09:41:16.658Z daily 0.7 https://novapharmanews.com/us/articles/asco-positive-data-bristol-pfizer-cancer 2026-06-03T09:18:44.755Z daily 0.7 https://novapharmanews.com/us/articles/replimune-third-attempt-cancer-drug-approval 2026-06-03T07:52:04.456Z daily 0.7 https://novapharmanews.com/us/articles/which-vaccines-curb-ebola-outbreak-who-debates 2026-06-03T07:20:20.540Z daily 0.7 https://novapharmanews.com/us/articles/fierce-pharma-asia-insights-deals-trends 2026-06-03T07:14:53.478Z daily 0.7 https://novapharmanews.com/us/articles/trump-administration-overhaul-federal-grantmaking 2026-06-03T07:10:15.218Z daily 0.7 https://novapharmanews.com/eu/articles/brand-name-drug-prices-us-global-impact 2026-06-03T06:49:20.938Z daily 0.7 https://novapharmanews.com/apac/articles/mannkind-pediatric-expansion-afrezza 2026-06-03T05:58:56.315Z daily 0.7 https://novapharmanews.com/us/articles/chaotic-fda-faster-drug-development 2026-06-03T05:35:43.618Z daily 0.7 https://novapharmanews.com/us/articles/fda-draft-guidance-animal-testing-cancer-drugs 2026-06-03T04:37:04.313Z daily 0.7 https://novapharmanews.com/us/articles/kenya-court-halts-ebola-quarantine-facility-plans 2026-06-03T04:26:16.387Z daily 0.7 https://novapharmanews.com/us/articles/bristol-myers-next-gen-blood-cancer-drug-data 2026-06-03T04:26:08.383Z daily 0.7 https://novapharmanews.com/eu/articles/dizal-takes-on-jj-egfr-lung-cancer 2026-06-03T04:26:04.380Z daily 0.7 https://novapharmanews.com/us/articles/pfizer-innovent-10b-cancer-drug-deal 2026-06-03T04:26:00.369Z daily 0.7 https://novapharmanews.com/us/articles/mannkind-pediatric-expansion-afrezza-sales-boost 2026-06-03T04:25:54.367Z daily 0.7 https://novapharmanews.com/us/articles/massachusetts-sues-unitedhealth-medicaid-fraud 2026-06-03T04:25:49.819Z daily 0.7 https://novapharmanews.com/us/articles/allogene-ceo-david-chang-steps-down 2026-06-03T04:25:42.344Z daily 0.7 https://novapharmanews.com/us/articles/allogene-ceo-departure-agios-drug-setback 2026-06-03T04:25:40.353Z daily 0.7 https://novapharmanews.com/eu/articles/from-promise-to-proof-biosimilar-market 2026-06-03T10:11:49.460Z daily 0.7 https://novapharmanews.com/eu/articles/ema-backs-novo-nordisk-wegovy-weight-loss 2026-06-03T07:45:15.357Z daily 0.7 https://novapharmanews.com/us/articles/merck-cornerstone-cancer-drug-asco 2026-06-03T07:34:07.468Z daily 0.7 https://novapharmanews.com/us/articles/zydus-therapeutics-saroglitazar-fda-priority-review 2026-06-03T07:24:29.310Z daily 0.7 https://novapharmanews.com/eu/articles/incyte-monjuvi-first-line-dlbcl 2026-06-03T05:32:40.204Z daily 0.7 https://novapharmanews.com/us/articles/ebola-response-trump-administration-shift 2026-06-03T05:08:17.103Z daily 0.7 https://novapharmanews.com/eu/articles/pfizer-talzenna-combo-prostate-cancer-win 2026-06-03T04:26:26.408Z daily 0.7 https://novapharmanews.com/us/articles/ebola-world-cup-worry 2026-06-03T10:41:31.698Z daily 0.7 https://novapharmanews.com/apac/articles/abbvie-fda-approval-immunogen-elahere 2026-06-03T08:06:31.570Z daily 0.7 https://novapharmanews.com/us/articles/abbvie-fda-approval-immunogen-elahere 2026-06-03T07:40:48.926Z daily 0.7 https://novapharmanews.com/eu/articles/cvs-eli-lilly-obesity-medications-coverage 2026-06-03T07:12:51.543Z daily 0.7 https://novapharmanews.com/us/articles/hepatitis-b-drug-lilly-obesity-drug-cvs 2026-06-03T07:09:19.208Z daily 0.7 https://novapharmanews.com/us/articles/cvs-obesity-drug-deal-lilly-novo 2026-06-03T04:26:58.452Z daily 0.7 https://novapharmanews.com/us/articles/trumps-pharma-deals-under-scrutiny 2026-06-03T04:26:56.439Z daily 0.7 https://novapharmanews.com/us/articles/stat-asco-preview-insights-pharma 2026-06-03T04:26:54.450Z daily 0.7 https://novapharmanews.com/us/articles/latest-developments-ebola-hepatitis-b-long-covid 2026-06-03T04:26:52.278Z daily 0.7 https://novapharmanews.com/us/articles/pharma-leaders-advocate-japan-rd-investment 2026-06-03T04:26:48.441Z daily 0.7 https://novapharmanews.com/us/articles/oura-cuffless-blood-pressure 2026-06-03T04:26:42.433Z daily 0.7 https://novapharmanews.com/eu/articles/pharmaessentia-eric-vogel-besremi-expansion 2026-06-03T04:26:38.421Z daily 0.7 https://novapharmanews.com/us/articles/blood-pressure-tech-floods-market-fda-oversight 2026-06-03T04:26:37.280Z daily 0.7 https://novapharmanews.com/us/articles/stat-ahead-of-asco-pancreatic-cancer 2026-06-03T04:26:36.425Z daily 0.7 https://novapharmanews.com/us/articles/astrazeneca-imfinzi-bladder-cancer-approval 2026-06-03T06:29:56.369Z daily 0.7 https://novapharmanews.com/us/articles/ebola-outbreak-response-us-fortification-strategies 2026-06-03T06:09:08.948Z daily 0.7 https://novapharmanews.com/us/articles/research-progress-antibody-oligonucleotide-conjugates 2026-06-03T05:09:48.785Z daily 0.7 https://novapharmanews.com/us/articles/biotech-strategic-turning-point-jeremy-levin 2026-06-03T05:01:47.438Z daily 0.7 https://novapharmanews.com/us/articles/fda-alert-infectious-diseases-drug-news-roundup-2026 2026-06-03T04:27:18.565Z daily 0.7 https://novapharmanews.com/eu/articles/regulatory-round-up-ema-may-2026 2026-06-03T04:27:16.475Z daily 0.7 https://novapharmanews.com/us/articles/fda-precheck-pilot-program-launches 2026-06-03T04:27:14.471Z daily 0.7 https://novapharmanews.com/us/articles/biotech-future-jeremey-levin-insights 2026-06-03T04:27:12.476Z daily 0.7 https://novapharmanews.com/eu/articles/eu-panel-backs-wider-uses-cancer-drugs 2026-06-03T04:27:04.446Z daily 0.7 https://novapharmanews.com/us/articles/gsk-ionis-hepatitis-b-drug-data 2026-06-03T04:27:00.542Z daily 0.7 https://novapharmanews.com/us/articles/asco-2026-event-coverage 2026-06-03T06:21:07.611Z daily 0.7 https://novapharmanews.com/us/articles/trumps-drug-pricing-deals-new-product-launches 2026-06-03T04:37:43.805Z daily 0.7 https://novapharmanews.com/us/articles/experimental-hepatitis-b-treatment-functional-cure 2026-06-03T04:27:22.473Z daily 0.7 https://novapharmanews.com/us/articles/verge-rebrands-ai-drug-discovery-trial-failure 2026-06-03T04:58:48.283Z daily 0.7 https://novapharmanews.com/us/articles/fda-delays-astrazeneca-breast-cancer-pill 2026-06-03T04:27:36.149Z daily 0.7 https://novapharmanews.com/us/articles/heart-patch-stem-cells-revved-up-weakened-hearts 2026-06-03T04:27:35.343Z daily 0.7 https://novapharmanews.com/eu/articles/viridian-wuxi-bio-eye-drug-supply-deal 2026-06-03T04:27:28.485Z daily 0.7 https://novapharmanews.com/us/articles/oligonucleotide-therapeutics-market-report-2033-clinical-trials 2026-06-03T10:04:43.851Z daily 0.7 https://novapharmanews.com/us/articles/nsf-pharma-biotech-conference-2026 2026-06-03T09:24:20.972Z daily 0.7 https://novapharmanews.com/apac/articles/rusan-pharma-launches-api-facility-pithampur 2026-06-03T04:27:43.819Z daily 0.7 https://novapharmanews.com/us/articles/fda-calendar-2026-approval-dates-pdufa-insights 2026-06-03T04:27:40.595Z daily 0.7 https://novapharmanews.com/us/articles/biotech-ipos-surge-ma-activity 2026-06-03T04:27:36.504Z daily 0.7 https://novapharmanews.com/eu/articles/ema-chmp-backs-four-new-medicines-may-meeting 2026-06-03T04:27:34.489Z daily 0.7 https://novapharmanews.com/eu/articles/kaleo-allergy-awareness-patient-stories 2026-06-03T04:27:46.513Z daily 0.7 https://novapharmanews.com/us/articles/potential-fda-approval-eye-drug 2026-06-03T11:20:56.291Z daily 0.7 https://novapharmanews.com/eu/articles/eli-lilly-noom-glp1-claims 2026-06-03T09:37:35.031Z daily 0.7 https://novapharmanews.com/us/articles/stat-patients-hospitals-disagree-ai 2026-06-03T09:10:27.347Z daily 0.7 https://novapharmanews.com/us/articles/kailera-triple-g-drug-game-changer 2026-06-03T07:17:14.981Z daily 0.7 https://novapharmanews.com/us/articles/jj-separates-orthopedics-layoffs-new-jersey 2026-06-03T05:38:17.169Z daily 0.7 https://novapharmanews.com/us/articles/trump-medical-exam-implications-pharma 2026-06-03T04:28:16.558Z daily 0.7 https://novapharmanews.com/us/articles/us-healthcare-opportunities-pricing-pressures 2026-06-03T04:28:08.547Z daily 0.7 https://novapharmanews.com/us/articles/kardigan-ipo-cardio-pharmaceuticals 2026-06-03T04:28:06.858Z daily 0.7 https://novapharmanews.com/apac/articles/biogen-investigation-italian-regulator-multiple-sclerosis 2026-06-03T04:28:04.539Z daily 0.7 https://novapharmanews.com/us/articles/kailera-obesity-shot-promise-trial 2026-06-03T04:28:03.017Z daily 0.7 https://novapharmanews.com/us/articles/asco-preview-akeso-ivonescimab-scrutiny 2026-06-03T04:28:02.533Z daily 0.7 https://novapharmanews.com/us/articles/apogee-eczema-drug-blackstone-phase-3 2026-06-03T04:28:00.533Z daily 0.7 https://novapharmanews.com/us/articles/cordenpharma-cdmo-deal-production-expansion 2026-06-03T04:27:54.537Z daily 0.7 https://novapharmanews.com/us/articles/astrazeneca-breast-cancer-pill-adap-deal-florida 2026-06-03T04:27:53.156Z daily 0.7 https://novapharmanews.com/us/articles/optimistic-scientists-losing-heart-mit 2026-06-03T04:27:50.524Z daily 0.7 https://novapharmanews.com/us/articles/are-we-just-going-to-give-up-and-die 2026-06-03T04:28:31.746Z daily 0.7 https://novapharmanews.com/us/articles/fda-delays-astra-zeneca-breast-cancer-drug 2026-06-03T04:28:28.623Z daily 0.7 https://novapharmanews.com/us/articles/sen-dick-durbin-trump-big-tobacco-children 2026-06-03T04:28:25.191Z daily 0.7 https://novapharmanews.com/us/articles/demand-unvaccinated-blood-transfusions 2026-06-03T04:28:24.628Z daily 0.7 https://novapharmanews.com/us/articles/stanford-patients-health-ai-adoption 2026-06-03T04:28:20.617Z daily 0.7 https://novapharmanews.com/us/articles/end-of-science-pharma-implications 2026-06-03T04:28:18.629Z daily 0.7 https://novapharmanews.com/us/articles/acadia-pharmaceuticals-parkinsons-campaign-ryan-reynolds 2026-06-03T04:35:34.446Z daily 0.7 https://novapharmanews.com/us/articles/gilead-hepcludex-fda-approval-hepatitis-d 2026-06-03T04:28:40.653Z daily 0.7 https://novapharmanews.com/us/articles/five-biotech-news-updates-stat 2026-06-03T04:28:38.637Z daily 0.7 https://novapharmanews.com/us/articles/ebola-outbreak-worsens-implications-women-girls 2026-06-03T04:28:36.643Z daily 0.7 https://novapharmanews.com/us/articles/eli-lilly-gene-therapy-cholesterol-deals 2026-06-03T04:28:32.636Z daily 0.7 https://novapharmanews.com/us/articles/utah-doctronic-ai-pilot-early-data 2026-06-03T04:28:30.626Z daily 0.7 https://novapharmanews.com/us/articles/coins-act-expansion-china-biotech-licensing 2026-06-03T10:52:18.290Z daily 0.7 https://novapharmanews.com/us/articles/astellas-cost-cuts-fda-moderna-vaccine 2026-06-03T09:14:25.461Z daily 0.7 https://novapharmanews.com/us/articles/lilly-vaccine-research-biotech-buyouts 2026-06-03T08:52:25.326Z daily 0.7 https://novapharmanews.com/us/articles/eli-lilly-verve-heart-drug-data 2026-06-03T04:36:57.601Z daily 0.7 https://novapharmanews.com/us/articles/praise-fda-acting-commissioner 2026-06-03T04:28:59.175Z daily 0.7 https://novapharmanews.com/us/articles/trump-annual-physical-pharma-implications 2026-06-03T04:28:56.659Z daily 0.7 https://novapharmanews.com/us/articles/mirum-fda-path-anti-itch-phase-2-win-oncology 2026-06-03T04:28:52.673Z daily 0.7 https://novapharmanews.com/us/articles/understanding-financial-implications-stat 2026-06-03T04:28:48.655Z daily 0.7 https://novapharmanews.com/us/articles/lantheus-curium-acquisition 2026-06-03T04:28:44.642Z daily 0.7 https://novapharmanews.com/us/articles/sk-bioscience-varicella-vaccine-colombia-deal 2026-06-03T04:28:42.650Z daily 0.7 https://novapharmanews.com/us/articles/china-biotech-venture-financing-simeon-george 2026-06-03T04:29:06.684Z daily 0.7 https://novapharmanews.com/eu/articles/europabio-food-feed-safety-omnibus-2026 2026-06-03T04:29:05.749Z daily 0.7 https://novapharmanews.com/us/articles/innovation-trap-pharma-monopolies 2026-06-03T04:29:02.671Z daily 0.7 https://novapharmanews.com/us/articles/process-intensification-fact-fiction 2026-06-03T04:29:26.702Z daily 0.7 https://novapharmanews.com/us/articles/targeted-protein-degraders-cancer 2026-06-03T04:29:24.697Z daily 0.7 https://novapharmanews.com/us/articles/measuring-what-matters-new-priorities-in-coa-selection 2026-06-03T04:29:22.706Z daily 0.7 https://novapharmanews.com/us/articles/unlocking-real-world-evidence-ai-era 2026-06-03T04:29:20.706Z daily 0.7 https://novapharmanews.com/us/articles/reforming-pepfar-insights-former-cdc-directors 2026-06-03T04:29:18.689Z daily 0.7 https://novapharmanews.com/us/articles/fda-grants-early-access-pancreatic-cancer-drug 2026-06-03T04:29:16.687Z daily 0.7 https://novapharmanews.com/us/articles/ai-drug-development-biotech-ceo-insights 2026-06-03T04:29:15.197Z daily 0.7 https://novapharmanews.com/apac/articles/rusan-pharma-gmp-milestone-pmda-approval 2026-06-03T04:29:14.683Z daily 0.7 https://novapharmanews.com/us/articles/ebola-outbreak-impact-women-girls 2026-06-03T04:29:12.700Z daily 0.7 https://novapharmanews.com/us/articles/kyle-diamantas-lead-fda 2026-06-03T04:29:08.692Z daily 0.7 https://novapharmanews.com/us/articles/appos-hartford-2026-preview 2026-06-03T04:29:28.709Z daily 0.7 https://novapharmanews.com/apac/articles/kelun-biotech-asco-2026-nsclc-presentation 2026-06-03T04:29:34.710Z daily 0.7 https://novapharmanews.com/us/articles/fda-approves-daraxonrasib-pancreatic-cancer 2026-06-03T04:29:32.705Z daily 0.7 https://novapharmanews.com/us/articles/eli-lilly-verve-gene-editor-cholesterol 2026-06-03T04:29:30.721Z daily 0.7 https://novapharmanews.com/us/articles/perimenopause-movement-hurt-women 2026-06-03T06:39:33.760Z daily 0.7 https://novapharmanews.com/eu/articles/abbvie-layoffs-allergan-aesthetics 2026-06-03T10:07:59.959Z daily 0.7 https://novapharmanews.com/us/articles/gop-lawmaker-china-biotech-deals 2026-06-03T09:37:12.885Z daily 0.7 https://novapharmanews.com/eu/articles/tyra-awareness-day-rare-cancer 2026-06-03T08:24:53.687Z daily 0.7 https://novapharmanews.com/us/articles/astrazeneca-eu-approval-breast-cancer-drug 2026-06-03T08:07:46.529Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-datroway-breast-cancer 2026-06-03T08:01:57.752Z daily 0.7 https://novapharmanews.com/us/articles/medicaid-funding-cuts-pharma-providers 2026-06-03T08:00:26.398Z daily 0.7 https://novapharmanews.com/us/articles/tender-offer-recordati-sobi-gout-drug-phase-3 2026-06-03T07:44:13.459Z daily 0.7 https://novapharmanews.com/us/articles/designing-future-ready-tech-roadmap-emerging-pharma 2026-06-03T07:30:39.660Z daily 0.7 https://novapharmanews.com/us/articles/astrazeneca-breast-cancer-drug-chmp-approval-fda-rejection 2026-06-03T07:09:04.686Z daily 0.7 https://novapharmanews.com/apac/articles/abbvie-gsk-patient-reputation-uk 2026-06-03T06:08:35.982Z daily 0.7 https://novapharmanews.com/us/articles/biogen-denali-parkinsons-drug-trial-failure 2026-06-03T04:29:48.729Z daily 0.7 https://novapharmanews.com/us/articles/astrazeneca-daiichi-fda-approval-datroway-tnbc 2026-06-03T04:29:42.712Z daily 0.7 https://novapharmanews.com/us/articles/five-key-regulatory-updates-asco 2026-06-03T11:22:40.269Z daily 0.7 https://novapharmanews.com/us/articles/abbvie-gsk-patient-reputation-uk 2026-06-03T09:39:56.498Z daily 0.7 https://novapharmanews.com/us/articles/novartis-abbvie-layoffs-pharma-industry 2026-06-03T09:24:10.257Z daily 0.7 https://novapharmanews.com/us/articles/asco26-data-snapshots-cancer-drug-meeting 2026-06-03T08:30:59.890Z daily 0.7 https://novapharmanews.com/us/articles/fda-approves-first-treatment-hdv-infection 2026-06-03T08:00:34.071Z daily 0.7 https://novapharmanews.com/apac/articles/merck-trofuse-005-trial-results 2026-06-03T07:32:40.009Z daily 0.7 https://novapharmanews.com/us/articles/utahs-ai-prescribing-experiment-progress-insights 2026-06-03T05:57:00.043Z daily 0.7 https://novapharmanews.com/us/articles/palvella-secures-230m-qtorin-rare-diseases 2026-06-03T04:30:10.761Z daily 0.7 https://novapharmanews.com/us/articles/fda-approves-gilead-hepatitis-d-drug 2026-06-03T04:30:06.947Z daily 0.7 https://novapharmanews.com/eu/articles/euroocs-annual-meeting-2026-preview 2026-06-03T11:06:08.136Z daily 0.7 https://novapharmanews.com/us/articles/resi-san-diego-2026-preview 2026-06-03T11:03:38.130Z daily 0.7 https://novapharmanews.com/us/articles/ai-doctor-office-check-ins 2026-06-03T11:14:20.168Z daily 0.7 https://novapharmanews.com/us/articles/novartis-avidity-science-beyond-muscular-dystrophies 2026-06-03T09:09:53.175Z daily 0.7 https://novapharmanews.com/us/articles/genentech-pharma-reforms-strategy 2026-06-03T09:00:44.540Z daily 0.7 https://novapharmanews.com/us/articles/merck-kelun-adc-strategic-wins-takeda-antitrust-loss 2026-06-03T08:59:54.907Z daily 0.7 https://novapharmanews.com/us/articles/parkinsons-drug-setback-merck-lung-cancer-therapy 2026-06-03T08:07:21.128Z daily 0.7 https://novapharmanews.com/us/articles/federal-office-mens-health-horizon 2026-06-03T08:05:06.786Z daily 0.7 https://novapharmanews.com/us/articles/eu-us-split-astra-zeneca-breast-cancer-drug 2026-06-03T06:09:41.321Z daily 0.7 https://novapharmanews.com/us/articles/seed-oil-panic-cardiac-health 2026-06-03T04:30:42.795Z daily 0.7 https://novapharmanews.com/us/articles/cdc-mpox-page-political-crosshairs 2026-06-03T04:30:40.791Z daily 0.7 https://novapharmanews.com/us/articles/biogen-denali-parkinsons-drug-study-setback 2026-06-03T04:30:36.787Z daily 0.7 https://novapharmanews.com/us/articles/health-ai-unicorn-free-services 2026-06-03T04:30:32.780Z daily 0.7 https://novapharmanews.com/us/articles/ibrance-heirs-gileads-tubulis-data-asco26 2026-06-03T04:30:26.777Z daily 0.7 https://novapharmanews.com/us/articles/asco26-head-neck-cancer-developments 2026-06-03T04:30:54.815Z daily 0.7 https://novapharmanews.com/us/articles/merck-kelun-lung-cancer-drug-tumor-progression-risk 2026-06-03T04:30:52.806Z daily 0.7 https://novapharmanews.com/us/articles/senators-grill-nih-director-key-insights-for-pharma 2026-06-03T04:30:50.806Z daily 0.7 https://novapharmanews.com/us/articles/asco26-kelun-phase-3-lung-cancer-success 2026-06-03T04:30:48.805Z daily 0.7 https://novapharmanews.com/us/articles/asco26-vegf-bispecifics-biontech-bms-pfizer-3sbio 2026-06-03T08:38:16.824Z daily 0.7 https://novapharmanews.com/eu/articles/roche-elevidys-eu-approval-update 2026-06-03T06:09:52.857Z daily 0.7 https://novapharmanews.com/us/articles/merck-kelun-adc-combo-keytruda-lung-cancer 2026-06-03T05:47:39.233Z daily 0.7 https://novapharmanews.com/us/articles/first-ras-inhibitor-extends-survival-metastatic-pancreatic-cancer 2026-06-03T04:31:11.227Z daily 0.7 https://novapharmanews.com/us/articles/roche-astra-zeneca-oncology-msl-team-survey 2026-06-03T04:31:10.834Z daily 0.7 https://novapharmanews.com/us/articles/mass-general-brigham-saving-lives-doctors-concerns 2026-06-03T04:31:04.814Z daily 0.7 https://novapharmanews.com/us/articles/stat-parkinsons-drug-fails-key-trial 2026-06-03T04:31:02.905Z daily 0.7 https://novapharmanews.com/apac/articles/kelun-biotech-skb118-approval 2026-06-03T04:31:02.129Z daily 0.7 https://novapharmanews.com/us/articles/ra-capital-biotech-spac-75m 2026-06-03T09:04:32.357Z daily 0.7 https://novapharmanews.com/us/articles/guarding-biotech-from-china-big-bets-longevity 2026-06-03T07:09:36.296Z daily 0.7 https://novapharmanews.com/us/articles/rfk-jr-screen-time-warning-pharma 2026-06-03T05:10:21.590Z daily 0.7 https://novapharmanews.com/us/articles/eli-lilly-fraud-allegations-trulicity 2026-06-03T04:47:56.784Z daily 0.7 https://novapharmanews.com/us/articles/biotechs-covert-campaign-fda-commissioner 2026-06-03T04:31:24.844Z daily 0.7 https://novapharmanews.com/us/articles/immunovant-shares-surge-arthritis-trial-data 2026-06-03T04:31:20.837Z daily 0.7 https://novapharmanews.com/eu/articles/ogilvy-health-ai-nano-influencers 2026-06-03T04:31:18.850Z daily 0.7 https://novapharmanews.com/us/articles/incyte-signs-ai-deals-genesis-edison 2026-06-03T10:33:07.189Z daily 0.7 https://novapharmanews.com/us/articles/big-pharma-q1-growth-insights 2026-06-03T10:04:57.388Z daily 0.7 https://novapharmanews.com/us/articles/chinas-drugmakers-asco26 2026-06-03T09:01:36.137Z daily 0.7 https://novapharmanews.com/us/articles/gilead-ambiosome-visceral-leishmaniasis 2026-06-03T06:05:53.442Z daily 0.7 https://novapharmanews.com/us/articles/biomarin-study-success-expansion 2026-06-03T06:04:59.836Z daily 0.7 https://novapharmanews.com/us/articles/bms-expansion-texas-novartis-tenant-eviction 2026-06-03T04:31:56.880Z daily 0.7 https://novapharmanews.com/us/articles/lilly-obesity-drug-trial-alzheimers-statistics 2026-06-03T04:31:54.876Z daily 0.7 https://novapharmanews.com/us/articles/biomarin-approval-voxzogo-short-stature 2026-06-03T04:31:52.886Z daily 0.7 https://novapharmanews.com/us/articles/senate-nih-director-2027-budget 2026-06-03T04:31:50.880Z daily 0.7 https://novapharmanews.com/us/articles/nih-infectious-disease-institute-leadership-change 2026-06-03T04:31:48.866Z daily 0.7 https://novapharmanews.com/us/articles/elevance-executive-testifies-medicare-advantage-fraud 2026-06-03T04:31:46.863Z daily 0.7 https://novapharmanews.com/us/articles/bristol-myers-alzheimers-promise-beyond-amyloid 2026-06-03T04:31:42.878Z daily 0.7 https://novapharmanews.com/us/articles/amgen-tavneos-label-update-japan 2026-06-03T04:31:42.287Z daily 0.7 https://novapharmanews.com/us/articles/florida-hospitals-medicaid-funds-strategic-overview 2026-06-03T04:31:36.858Z daily 0.7 https://novapharmanews.com/us/articles/biomarin-voxzogo-label-expansion 2026-06-03T04:31:32.851Z daily 0.7 https://novapharmanews.com/us/articles/lilly-triple-acting-obesity-drug-phase-3-trial 2026-06-03T04:31:30.852Z daily 0.7 https://novapharmanews.com/us/articles/whoop-fda-blood-pressure-feature-discussions 2026-06-03T06:29:38.369Z daily 0.7 https://novapharmanews.com/us/articles/eli-lilly-triple-g-drug-weight-loss-trial 2026-06-03T06:24:17.728Z daily 0.7 https://novapharmanews.com/eu/articles/tarsus-john-cena-demodex-blepharitis-campaign 2026-06-03T06:00:09.982Z daily 0.7 https://novapharmanews.com/us/articles/dark-times-ahead-at-the-fda 2026-06-03T04:32:24.912Z daily 0.7 https://novapharmanews.com/us/articles/ai-co-scientist-tools-useful 2026-06-03T04:32:22.901Z daily 0.7 https://novapharmanews.com/us/articles/long-term-medical-consequences-bullet-fragments 2026-06-03T04:32:20.904Z daily 0.7 https://novapharmanews.com/eu/articles/ipsen-transition-adult-care 2026-06-03T04:32:18.893Z daily 0.7 https://novapharmanews.com/eu/articles/roche-xofluza-licensing-deal 2026-06-03T04:32:16.900Z daily 0.7 https://novapharmanews.com/eu/articles/cg-life-collette-douaihy-appointment 2026-06-03T04:32:14.900Z daily 0.7 https://novapharmanews.com/eu/articles/gilead-yuhan-140m-deal 2026-06-03T04:32:12.894Z daily 0.7 https://novapharmanews.com/eu/articles/amgen-cfo-transition-galderma-exec 2026-06-03T04:32:11.050Z daily 0.7 https://novapharmanews.com/eu/articles/beone-one-save-changes-everything-campaign-tim-howard 2026-06-03T04:32:04.888Z daily 0.7 https://novapharmanews.com/us/articles/lilly-triple-agonist-obesity-assets 2026-06-03T04:32:02.883Z daily 0.7 https://novapharmanews.com/eu/articles/ucb-bimzelx-skyrizi-psoriatic-arthritis-win 2026-06-03T04:32:00.881Z daily 0.7 https://novapharmanews.com/eu/articles/germany-bioeconomy-dialogue-pharma-implications 2026-06-03T04:32:26.919Z daily 0.7 https://novapharmanews.com/us/articles/fda-warning-illegal-tobacco-products 2026-06-03T04:32:41.832Z daily 0.7 https://novapharmanews.com/us/articles/kennedy-interim-surgeon-general-pharma-implications 2026-06-03T04:32:36.919Z daily 0.7 https://novapharmanews.com/us/articles/pfizers-next-gen-pneumonia-shot-prevnar-20 2026-06-03T04:32:32.921Z daily 0.7 https://novapharmanews.com/us/articles/ucb-bimzelx-vs-abbvie-skyrizi-competitive-analysis 2026-06-03T04:32:30.923Z daily 0.7 https://novapharmanews.com/us/articles/parabilis-ipo-plans-regeneron-deal 2026-06-03T04:32:28.915Z daily 0.7 https://novapharmanews.com/us/articles/fetal-gene-therapy-embryo-editing-taboo 2026-06-03T10:26:32.236Z daily 0.7 https://novapharmanews.com/us/articles/bms-anthropic-ai-adoption 2026-06-03T09:17:20.096Z daily 0.7 https://novapharmanews.com/us/articles/ebola-doctor-patient-perspective 2026-06-03T08:50:03.765Z daily 0.7 https://novapharmanews.com/us/articles/gho-capital-cbc-group-merger-healthcare-investment 2026-06-03T07:52:26.465Z daily 0.7 https://novapharmanews.com/us/articles/immunitybio-anktiva-fda-decision-date 2026-06-03T07:03:11.641Z daily 0.7 https://novapharmanews.com/us/articles/kennedy-leadership-shakeup-preventive-services 2026-06-03T06:33:16.765Z daily 0.7 https://novapharmanews.com/us/articles/gilead-yuhan-deal-tracker 2026-06-03T05:39:03.198Z daily 0.7 https://novapharmanews.com/us/articles/bristol-myers-anthropic-ai-investment 2026-06-03T04:53:22.675Z daily 0.7 https://novapharmanews.com/us/articles/tracking-cellular-disruptions-type-1-diabetes 2026-06-03T04:33:12.973Z daily 0.7 https://novapharmanews.com/us/articles/oorja-launches-new-fibrosis-drugs 2026-06-03T04:33:10.967Z daily 0.7 https://novapharmanews.com/us/articles/amgen-cfo-transition-galderma-exec 2026-06-03T04:33:06.980Z daily 0.7 https://novapharmanews.com/us/articles/parabilis-ipo-undruggable-targets 2026-06-03T04:33:02.957Z daily 0.7 https://novapharmanews.com/us/articles/ipsen-transition-challenges-pharma-teams 2026-06-03T04:33:01.016Z daily 0.7 https://novapharmanews.com/us/articles/glp-1s-pharma-consumer-relationships 2026-06-03T04:32:54.952Z daily 0.7 https://novapharmanews.com/us/articles/ii-biotech-campfield-180m-series-a-funding 2026-06-03T04:32:50.941Z daily 0.7 https://novapharmanews.com/us/articles/impact-fda-turnover-rare-disease-drug-development 2026-06-03T04:32:42.940Z daily 0.7 https://novapharmanews.com/us/articles/beone-one-save-changes-everything-campaign 2026-06-03T04:32:40.918Z daily 0.7 https://novapharmanews.com/us/articles/tarsus-john-cena-demodex-blepharitis-campaign 2026-06-03T04:32:38.935Z daily 0.7 https://novapharmanews.com/us/articles/bbsw-ai-solution-2026-event-coverage 2026-06-03T10:55:05.100Z daily 0.7 https://novapharmanews.com/us/articles/regulatory-education-2026 2026-06-03T08:56:45.770Z daily 0.7 https://novapharmanews.com/us/articles/paragon-reverse-merger-migraine-drugs 2026-06-03T07:17:59.976Z daily 0.7 https://novapharmanews.com/us/articles/asgct-annual-meeting-2026-coverage 2026-06-03T05:53:03.244Z daily 0.7 https://novapharmanews.com/apac/articles/merck-kelun-trop2-regulatory-updates 2026-06-03T04:33:28.980Z daily 0.7 https://novapharmanews.com/us/articles/acceleron-westlake-ipf-biotech-launch 2026-06-03T04:33:22.976Z daily 0.7 https://novapharmanews.com/us/articles/pharma-manufacturing-world-2026-coverage 2026-06-03T04:33:20.970Z daily 0.7 https://novapharmanews.com/us/articles/atara-bounces-back-fda-oncology 2026-06-03T04:33:20.901Z daily 0.7 https://novapharmanews.com/us/articles/gilead-yuhan-140m-deal 2026-06-03T10:12:09.252Z daily 0.7 https://novapharmanews.com/us/articles/redi-2026-conference-coverage 2026-06-03T05:12:43.281Z daily 0.7 https://novapharmanews.com/eu/articles/pharma-partnering-eu-2026-coverage 2026-06-03T04:33:43.004Z daily 0.7 https://novapharmanews.com/us/articles/drugmakers-ip-protections-china-competition 2026-06-03T04:33:41.017Z daily 0.7 https://novapharmanews.com/us/articles/migraine-drugmaker-reverse-merger 2026-06-03T04:33:39.005Z daily 0.7 https://novapharmanews.com/us/articles/white-house-trumprx-portal-expansion 2026-06-03T04:33:36.996Z daily 0.7 https://novapharmanews.com/us/articles/navigating-the-data-2026 2026-06-03T04:33:32.998Z daily 0.7 https://novapharmanews.com/us/articles/kennedy-fires-leaders-preventive-services-task-force 2026-06-03T10:39:58.660Z daily 0.7 https://novapharmanews.com/us/articles/ii-biotech-campfield-180m-series-a-investment 2026-06-03T10:20:47.039Z daily 0.7 https://novapharmanews.com/us/articles/oorja-launches-new-fibrosis-drug-development 2026-06-03T10:14:07.023Z daily 0.7 https://novapharmanews.com/us/articles/roche-xofluza-licensing-deal 2026-06-03T09:59:12.316Z daily 0.7 https://novapharmanews.com/us/articles/clinical-research-patient-2026 2026-06-03T09:19:45.870Z daily 0.7 https://novapharmanews.com/us/articles/redi-2026-conference-event-coverage 2026-06-03T09:16:19.276Z daily 0.7 https://novapharmanews.com/us/articles/congressional-democrats-end-medicare-ai-pilot 2026-06-03T07:55:19.883Z daily 0.7 https://novapharmanews.com/eu/articles/beone-one-save-changes-everything-campaign 2026-06-03T04:34:07.031Z daily 0.7 https://novapharmanews.com/us/articles/florida-hospitals-8-billion-medicaid-funds 2026-06-03T04:34:03.025Z daily 0.7 https://novapharmanews.com/us/articles/cg-life-collette-douaihy-appointment 2026-06-03T04:33:55.016Z daily 0.7 https://novapharmanews.com/us/articles/stat-pioneering-trial-genetic-disease 2026-06-03T04:33:51.013Z daily 0.7 https://novapharmanews.com/us/articles/cg-life-collette-douaihy-cco-appointment 2026-06-03T04:33:45.001Z daily 0.7 https://novapharmanews.com/us/articles/palvella-pivotal-rare-disease-data-financial-outlook 2026-06-03T10:50:22.404Z daily 0.7 https://novapharmanews.com/eu/articles/cg-life-appoints-collette-douaihy-cco 2026-06-03T10:30:50.025Z daily 0.7 https://novapharmanews.com/us/articles/cg-life-appoints-collette-douaihy-chief-creative-officer 2026-06-03T07:35:33.176Z daily 0.7 https://novapharmanews.com/apac/articles/amgen-cfo-departure-galderma-strategic-move 2026-06-03T04:34:27.278Z daily 0.7 https://novapharmanews.com/eu/articles/maat-pharma-regulatory-update-maat013-xervyteg 2026-06-03T04:34:25.296Z daily 0.7 https://novapharmanews.com/us/articles/ebola-doctor-patient-perspectives 2026-06-03T04:34:23.298Z daily 0.7 https://novapharmanews.com/apac/articles/bms-anthropic-ai-adoption 2026-06-03T04:34:19.266Z daily 0.7 https://novapharmanews.com/us/articles/leadership-changes-preventive-services-task-force 2026-06-03T04:34:16.032Z daily 0.7 https://novapharmanews.com/us/articles/eli-lilly-engage-acquisition-genetic-medicine 2026-06-03T04:34:15.045Z daily 0.7 https://novapharmanews.com/eu/articles/pharma-partnering-eu-2026 2026-06-03T04:34:09.040Z daily 0.7 https://novapharmanews.com/us/articles/eli-lilly-acquires-engage-genetic-medicine 2026-06-03T11:07:43.239Z daily 0.7 https://novapharmanews.com/eu/articles/impharma2026-preview 2026-06-03T10:58:04.395Z daily 0.7 https://novapharmanews.com/us/articles/bbsw-ai-solution-2026-coverage 2026-06-03T09:41:28.113Z daily 0.7 https://novapharmanews.com/us/articles/parabilis-raises-800m-ipo-undruggable-targets 2026-06-03T08:06:12.099Z daily 0.7 https://novapharmanews.com/us/articles/immunovant-wave-autoimmune-innovations 2026-06-03T06:21:26.012Z daily 0.7 https://novapharmanews.com/us/articles/drug-discovery-usa-2026-preview 2026-06-03T04:34:45.301Z daily 0.7 https://novapharmanews.com/apac/articles/cg-life-new-chief-creative-officer-implications 2026-06-03T04:34:41.405Z daily 0.7 https://novapharmanews.com/eu/articles/hlth-europe-2026-preview 2026-06-03T04:34:39.294Z daily 0.7 https://novapharmanews.com/apac/articles/logipharma-asia-2026-preview 2026-06-03T04:34:31.294Z daily 0.7 https://novapharmanews.com/us/articles/clinical-research-patient-2026-preview 2026-06-03T08:03:59.569Z daily 0.7 https://novapharmanews.com/us/articles/23andme-connects-dna-data-medical-records 2026-06-03T04:34:59.320Z daily 0.7 https://novapharmanews.com/us/articles/streamlined-rd-novo-nordisk 2026-06-03T04:34:57.314Z daily 0.7 https://novapharmanews.com/us/articles/marc-tessier-lavigne-responds-allegations-stanford-case 2026-06-03T04:34:55.324Z daily 0.7 https://novapharmanews.com/us/articles/current-landscape-consumer-health 2026-06-03T04:34:53.335Z daily 0.7 https://novapharmanews.com/us/articles/novartis-terminates-contract-porton-implications 2026-06-03T04:34:49.326Z daily 0.7 https://novapharmanews.com/us/articles/takeda-885m-verdict-pay-delay-antitrust 2026-06-03T04:34:47.302Z daily 0.7 https://novapharmanews.com/us/articles/supreme-court-decision-ira-challenges-pharma 2026-06-03T10:53:45.758Z daily 0.7 https://novapharmanews.com/us/articles/who-defense-ebola-response 2026-06-03T09:05:36.702Z daily 0.7 https://novapharmanews.com/us/articles/beone-one-save-changes-everything-campaign-tim-howard 2026-06-03T07:34:28.850Z daily 0.7 https://novapharmanews.com/us/articles/leadership-challenges-at-nih 2026-06-03T06:12:31.264Z daily 0.7 https://novapharmanews.com/us/articles/biotech-investors-mood-fda-insights 2026-06-03T05:53:24.522Z daily 0.7 https://novapharmanews.com/us/articles/biomarin-drug-acquisition-missed-goals-rare-disease-study 2026-06-03T04:35:21.009Z daily 0.7 https://novapharmanews.com/us/articles/nih-leadership-gaps-pharmaceutical-industry 2026-06-03T04:35:17.524Z daily 0.7 https://novapharmanews.com/us/articles/state-of-consumer-health-trends-insights 2026-06-03T04:35:03.333Z daily 0.7 https://novapharmanews.com/us/articles/who-defends-ebola-response-rubio-critique 2026-06-03T04:35:01.330Z daily 0.7 https://novapharmanews.com/us/articles/kennedy-leadership-shakeup-preventive-services-task-force 2026-06-03T10:39:58.659Z daily 0.7 https://novapharmanews.com/us/articles/next-big-pharma-company-china 2026-06-03T04:35:19.520Z daily 0.7 https://novapharmanews.com/us/articles/cg-life-c-suite-expansion-collette-douaihy 2026-06-03T10:26:26.381Z daily 0.7 https://novapharmanews.com/us/articles/amgen-cfo-departure-galderma-exec 2026-06-03T06:55:48.248Z daily 0.7 https://novapharmanews.com/eu/articles/amgen-cfo-departure-galderma-executive 2026-06-03T04:35:37.694Z daily 0.7 https://novapharmanews.com/eu/articles/cg-life-appoints-collette-douaihy-chief-creative-officer 2026-06-03T04:35:33.536Z daily 0.7 https://novapharmanews.com/us/articles/openevidence-hospital-pitch 2026-06-03T04:35:31.544Z daily 0.7 https://novapharmanews.com/us/articles/oorja-launches-new-fibrosis-drugs-acceleron-veterans 2026-06-03T04:35:25.527Z daily 0.7 https://novapharmanews.com/apac/articles/beone-one-save-changes-everything-campaign 2026-06-03T04:35:23.529Z daily 0.7 https://novapharmanews.com/us/articles/merck-kelun-sac-tmt-endometrial-cancer-trial 2026-06-03T07:42:23.491Z daily 0.7 https://novapharmanews.com/us/articles/relays-pi3ka-inhibitor-phase-2-study 2026-06-03T07:30:54.285Z daily 0.7 https://novapharmanews.com/us/articles/roche-alecensa-japan-expansion 2026-06-03T04:35:51.567Z daily 0.7 https://novapharmanews.com/eu/articles/bristol-myers-houston-manufacturing-plant 2026-06-03T04:35:49.557Z daily 0.7 https://novapharmanews.com/apac/articles/roche-alecensa-japan-expansion 2026-06-03T04:35:45.558Z daily 0.7 https://novapharmanews.com/us/articles/bristol-myers-houston-manufacturing-plant 2026-06-03T04:35:41.559Z daily 0.7 https://novapharmanews.com/us/articles/biomarin-rare-disease-therapy-phase-3-trial-failure 2026-06-03T04:35:39.557Z daily 0.7 https://novapharmanews.com/us/articles/future-uses-cgm-dexcom-ceo-insights 2026-06-03T04:35:37.543Z daily 0.7 https://novapharmanews.com/us/articles/trumprx-adds-generic-drugs 2026-06-03T09:29:37.165Z daily 0.7 https://novapharmanews.com/us/articles/virginia-governor-vetoes-drug-cost-panel 2026-06-03T08:47:20.221Z daily 0.7 https://novapharmanews.com/us/articles/regulatory-education-2026-preview 2026-06-03T08:09:16.388Z daily 0.7 https://novapharmanews.com/us/articles/trumps-cuts-foreign-aid-ebola-response 2026-06-03T07:26:29.753Z daily 0.7 https://novapharmanews.com/us/articles/spine-surgery-cost-no-surprises-act 2026-06-03T04:35:57.563Z daily 0.7 https://novapharmanews.com/us/articles/ai-treatment-newborn-ultra-rare-disease 2026-06-03T04:35:55.567Z daily 0.7 https://novapharmanews.com/us/articles/fda-future-david-kessler-insights 2026-06-03T04:35:53.568Z daily 0.7 https://novapharmanews.com/us/articles/ai-treatment-ultra-rare-disease-newborns 2026-06-03T07:07:02.372Z daily 0.7 https://novapharmanews.com/eu/articles/slas-europe-2026-event-coverage 2026-06-03T04:36:29.629Z daily 0.7 https://novapharmanews.com/us/articles/senate-democrats-long-term-care-benefit-medicare 2026-06-03T04:36:27.621Z daily 0.7 https://novapharmanews.com/us/articles/rise-of-perimenopause-misinformation 2026-06-03T04:36:25.630Z daily 0.7 https://novapharmanews.com/eu/articles/trumprx-generic-meds-initiative 2026-06-03T04:36:21.610Z daily 0.7 https://novapharmanews.com/us/articles/supreme-court-ira-ruling-pharma-deals 2026-06-03T04:36:19.613Z daily 0.7 https://novapharmanews.com/us/articles/scope-x-2026-event-coverage 2026-06-03T04:36:17.622Z daily 0.7 https://novapharmanews.com/us/articles/openevidence-pitch-hospitals 2026-06-03T04:36:15.607Z daily 0.7 https://novapharmanews.com/us/articles/navigating-the-data-2026-pre-event 2026-06-03T04:36:13.619Z daily 0.7 https://novapharmanews.com/us/articles/ispor-2026-event-coverage 2026-06-03T04:36:11.611Z daily 0.7 https://novapharmanews.com/eu/articles/astrazeneca-fda-approval-hypertension-fasenra 2026-06-03T04:36:09.596Z daily 0.7 https://novapharmanews.com/us/articles/trump-foreign-aid-cuts-ebola-response 2026-06-03T04:36:07.597Z daily 0.7 https://novapharmanews.com/us/articles/virginia-governor-vetoes-prescription-drug-costs 2026-06-03T11:14:58.408Z daily 0.7 https://novapharmanews.com/eu/articles/novartis-terminates-cdmo-contract-porton 2026-06-03T09:20:29.777Z daily 0.7 https://novapharmanews.com/us/articles/openevidence-pitches-hospitals 2026-06-03T08:32:17.671Z daily 0.7 https://novapharmanews.com/us/articles/impact-600-generic-meds-trumprx-portal 2026-06-03T06:49:04.709Z daily 0.7 https://novapharmanews.com/apac/articles/takeda-885m-verdict-pay-delay-antitrust-case 2026-06-03T04:36:39.632Z daily 0.7 https://novapharmanews.com/us/articles/canadian-medical-societies-conflict-of-interest-policies 2026-06-03T08:04:44.461Z daily 0.7 https://novapharmanews.com/us/articles/marc-tessier-lavigne-responds-allegations 2026-06-03T04:36:47.651Z daily 0.7 https://novapharmanews.com/us/articles/no-surprises-act-spine-surgery-costs-skyrocket 2026-06-03T04:36:45.647Z daily 0.7 https://novapharmanews.com/us/articles/biomarin-drug-acquisition-study-setback 2026-06-03T04:36:41.635Z daily 0.7 https://novapharmanews.com/us/articles/fda-shakeup-hoeg-fired-amgen-drug-controversy 2026-06-03T04:36:54.140Z daily 0.7 https://novapharmanews.com/eu/articles/biodefence-biosecurity-europabio-task-force 2026-06-03T04:36:53.908Z daily 0.7 https://novapharmanews.com/us/articles/bio-it-world-conference-2026-live-coverage 2026-06-03T04:36:49.648Z daily 0.7 https://novapharmanews.com/us/articles/stat-rd-performance-rankings-pharma 2026-06-03T08:11:09.052Z daily 0.7 https://novapharmanews.com/us/articles/fda-unreleased-covid-vaccine-deaths-report 2026-06-03T04:37:03.672Z daily 0.7 https://novapharmanews.com/us/articles/palvella-nasdaq-uplisting-rare-disease 2026-06-03T04:37:01.681Z daily 0.7 https://novapharmanews.com/us/articles/britain-tobacco-regulation-massachusetts-experiment 2026-06-03T04:36:57.659Z daily 0.7 https://novapharmanews.com/us/articles/amgen-tavneos-japan-liver-toxicity-report 2026-06-03T04:36:56.089Z daily 0.7 https://novapharmanews.com/us/articles/supreme-court-setback-pharma-trumprx-expansion 2026-06-03T08:45:23.057Z daily 0.7 https://novapharmanews.com/us/articles/stat-rd-performance-ranking-pharma 2026-06-03T04:54:50.081Z daily 0.7 https://novapharmanews.com/us/articles/migraine-drugmaker-public-market-reverse-merger 2026-06-03T04:37:09.678Z daily 0.7 https://novapharmanews.com/us/articles/supreme-court-pharma-pricing-deals 2026-06-03T04:37:07.699Z daily 0.7 https://novapharmanews.com/us/articles/canadian-medical-societies-conflict-of-interest 2026-06-03T09:36:09.087Z daily 0.7 https://novapharmanews.com/us/articles/wave-monthly-dosing-rna-editing-aatd 2026-06-03T09:04:23.482Z daily 0.7 https://novapharmanews.com/eu/articles/global-pharma-tech-2026 2026-06-03T04:37:19.697Z daily 0.7 https://novapharmanews.com/us/articles/spine-surgery-no-surprises-act-arbitration 2026-06-03T04:37:17.703Z daily 0.7 https://novapharmanews.com/us/articles/impact-600-new-generic-meds-pharma-landscape 2026-06-03T10:57:22.441Z daily 0.7 https://novapharmanews.com/us/articles/novartis-terminates-porton-contract 2026-06-03T10:41:46.494Z daily 0.7 https://novapharmanews.com/us/articles/no-surprises-act-spine-surgery-costs 2026-06-03T07:47:03.275Z daily 0.7 https://novapharmanews.com/eu/articles/ema-critical-medicines-act-2023 2026-06-03T04:37:27.714Z daily 0.7 https://novapharmanews.com/eu/articles/global-pharma-tech-2026-event-coverage 2026-06-03T05:39:48.098Z daily 0.7 https://novapharmanews.com/us/articles/waked-med-atrium-health-merger-significance 2026-06-03T09:36:55.682Z daily 0.7 https://novapharmanews.com/us/articles/supreme-court-drugmakers-ira-cases 2026-06-03T04:37:39.736Z daily 0.7 https://novapharmanews.com/us/articles/trump-cms-skimpier-plans-aca-exchanges 2026-06-03T04:37:38.430Z daily 0.7 https://novapharmanews.com/us/articles/medical-affairs-impact-launch 2026-06-03T04:37:33.709Z daily 0.7 https://novapharmanews.com/us/articles/eli-lilly-caitlin-clark-sports-courts-indianapolis 2026-06-03T04:37:31.707Z daily 0.7 https://novapharmanews.com/us/articles/ghost-approval-heart-transplant-medications 2026-06-03T09:58:45.839Z daily 0.7 https://novapharmanews.com/us/articles/biomarin-rare-disease-therapy-phase-3-results 2026-06-03T09:37:12.183Z daily 0.7 https://novapharmanews.com/us/articles/fda-shakeup-hoeg-amgen-drug-concerns 2026-06-03T05:54:17.618Z daily 0.7 https://novapharmanews.com/us/articles/impact-alcohol-consumption-pregnancy-pharma 2026-06-03T05:34:21.004Z daily 0.7 https://novapharmanews.com/eu/articles/driving-impact-at-launch-medical-affairs 2026-06-03T04:38:07.802Z daily 0.7 https://novapharmanews.com/us/articles/navigating-ghost-approval-heart-transplant-medication 2026-06-03T04:38:06.813Z daily 0.7 https://novapharmanews.com/us/articles/white-house-amazon-goodrx-mark-cuban-trumprx 2026-06-03T04:38:05.772Z daily 0.7 https://novapharmanews.com/eu/articles/europabio-biomanufacturing-policy-summit-2026 2026-06-03T04:37:59.817Z daily 0.7 https://novapharmanews.com/us/articles/amgen-tavneos-liver-toxicity-japan 2026-06-03T04:37:57.776Z daily 0.7 https://novapharmanews.com/us/articles/ebola-outbreak-experts-consider-unapproved-vaccine-testing 2026-06-03T04:37:55.760Z daily 0.7 https://novapharmanews.com/us/articles/latest-on-ebola-travel-ban-old-vaccine 2026-06-03T04:37:53.762Z daily 0.7 https://novapharmanews.com/us/articles/maryland-caps-ozempic-price 2026-06-03T04:37:51.767Z daily 0.7 https://novapharmanews.com/us/articles/regeneron-phase-3-skin-cancer-lag-3-failures 2026-06-03T04:37:45.753Z daily 0.7 https://novapharmanews.com/eu/articles/eli-lilly-caitlin-clark-sports-courts-indianapolis 2026-06-03T04:37:41.759Z daily 0.7 https://novapharmanews.com/us/articles/full-life-technologies-quince-pulmonary-drug 2026-06-03T04:38:19.803Z daily 0.7 https://novapharmanews.com/us/articles/relay-drug-promise-rare-blood-vessel-diseases 2026-06-03T04:38:17.792Z daily 0.7 https://novapharmanews.com/us/articles/nourish-secures-100m-virtual-nutrition-care 2026-06-03T04:38:15.777Z daily 0.7 https://novapharmanews.com/us/articles/ghost-approval-heart-transplant-medication 2026-06-03T04:38:13.800Z daily 0.7 https://novapharmanews.com/us/articles/alcohol-consumption-pregnancy-impact 2026-06-03T04:38:11.781Z daily 0.7 https://novapharmanews.com/us/articles/nourish-raises-100m-virtual-nutrition-care 2026-06-03T04:38:09.777Z daily 0.7 https://novapharmanews.com/apac/articles/kelun-biotech-sk118-cde-approval 2026-06-03T04:38:21.800Z daily 0.7 https://novapharmanews.com/us/articles/china-question-tearing-biotech-apart 2026-06-03T11:14:04.127Z daily 0.7 https://novapharmanews.com/us/articles/texas-opens-detransition-clinic 2026-06-03T09:51:01.055Z daily 0.7 https://novapharmanews.com/us/articles/fda-approves-astrazeneca-baxdrostat-hypertension 2026-06-03T04:38:30.171Z daily 0.7 https://novapharmanews.com/us/articles/from-reach-to-relevance-pharma-marketing 2026-06-03T06:24:48.559Z daily 0.7 https://novapharmanews.com/eu/articles/medical-affairs-impact-launch 2026-06-03T04:38:37.812Z daily 0.7 https://novapharmanews.com/us/articles/design-therapeutics-vincentage-data-insights 2026-06-03T04:38:35.810Z daily 0.7 https://novapharmanews.com/us/articles/regeneron-parabilis-deal-drug-targets 2026-06-03T04:38:33.830Z daily 0.7 https://novapharmanews.com/eu/articles/future-ai-pharma-marketing-cmi-media-group 2026-06-03T04:38:29.806Z daily 0.7 https://novapharmanews.com/us/articles/wakemed-atrium-health-merger-implications 2026-06-03T10:33:50.757Z daily 0.7 https://novapharmanews.com/us/articles/regeneron-phase-3-skin-cancer-miss-lag-3 2026-06-03T09:24:23.984Z daily 0.7 https://novapharmanews.com/us/articles/friedreichs-ataxia-obesity-results 2026-06-03T07:57:10.226Z daily 0.7 https://novapharmanews.com/us/articles/us-bans-entry-ebola-affected-countries 2026-06-03T04:38:52.883Z daily 0.7 https://novapharmanews.com/us/articles/amgen-tavneos-japan-liver-toxicity 2026-06-03T04:38:47.821Z daily 0.7 https://novapharmanews.com/us/articles/astrazeneca-fda-approval-hypertension-drug 2026-06-03T04:38:45.820Z daily 0.7 https://novapharmanews.com/us/articles/trump-cms-aca-exchanges-catastrophic-coverage 2026-06-03T04:38:43.853Z daily 0.7 https://novapharmanews.com/us/articles/ebola-outbreak-testing-long-shot-vaccines 2026-06-03T04:38:59.839Z daily 0.7 https://novapharmanews.com/apac/articles/eli-lilly-caitlin-clark-sports-courts-indianapolis 2026-06-03T04:38:57.841Z daily 0.7 https://novapharmanews.com/eu/articles/eli-lilly-caitlin-clark-indianapolis-sports-courts 2026-06-03T04:38:55.828Z daily 0.7 https://novapharmanews.com/eu/articles/daiichi-astrazeneca-enhertu-early-breast-cancer-approval 2026-06-03T04:38:53.886Z daily 0.7 https://novapharmanews.com/us/articles/eli-lilly-caitlin-clark-community-engagement 2026-06-03T10:52:26.735Z daily 0.7 https://novapharmanews.com/eu/articles/novartis-terminates-porton-contract 2026-06-03T10:41:46.503Z daily 0.7 https://novapharmanews.com/us/articles/waked-med-atrium-health-merger-matters 2026-06-03T05:45:12.896Z daily 0.7 https://novapharmanews.com/eu/articles/daiichi-astrazeneca-enhertu-fda-approvals-analysis 2026-06-03T04:39:05.842Z daily 0.7 https://novapharmanews.com/eu/articles/nice-approves-imfinzi-stomach-cancer-regulatory-update 2026-06-03T04:39:01.847Z daily 0.7 https://novapharmanews.com/us/articles/stat-wakemed-atrium-health-merger 2026-06-03T10:00:37.663Z daily 0.7 https://novapharmanews.com/us/articles/future-ai-pharma-marketing 2026-06-03T09:17:51.146Z daily 0.7 https://novapharmanews.com/us/articles/eli-lilly-sports-initiatives-indianapolis 2026-06-03T08:58:34.656Z daily 0.7 https://novapharmanews.com/us/articles/design-therapeutics-friedreichs-ataxia-vincentage-obesity-results 2026-06-03T07:53:40.308Z daily 0.7 https://novapharmanews.com/eu/articles/global-pharma-tech-2026-coverage 2026-06-03T04:39:21.871Z daily 0.7 https://novapharmanews.com/us/articles/enhertu-dual-fda-approvals-early-breast-cancer 2026-06-03T04:39:11.851Z daily 0.7 https://novapharmanews.com/us/articles/roche-ctdna-approach-bladder-cancer-tecentriq 2026-06-03T10:44:09.910Z daily 0.7 https://novapharmanews.com/us/articles/wegovy-pill-scripts-decline-pharma-implications 2026-06-03T07:43:24.926Z daily 0.7 https://novapharmanews.com/us/articles/understanding-fda-response-marty-makary 2026-06-03T06:11:56.363Z daily 0.7 https://novapharmanews.com/us/articles/cloudy-truth-blue-zones 2026-06-03T04:39:39.893Z daily 0.7 https://novapharmanews.com/us/articles/eisai-leqembi-sales-forecast 2026-06-03T04:39:37.878Z daily 0.7 https://novapharmanews.com/us/articles/navigating-new-policy-landscape-pharma 2026-06-03T04:39:33.889Z daily 0.7 https://novapharmanews.com/apac/articles/doceree-daily-command-ai-platform 2026-06-03T04:39:31.873Z daily 0.7 https://novapharmanews.com/us/articles/cder-leadership-changes-fda 2026-06-03T04:39:27.880Z daily 0.7 https://novapharmanews.com/apac/articles/scotus-telehealth-access-mifepristone 2026-06-03T04:39:25.862Z daily 0.7 https://novapharmanews.com/us/articles/nice-approves-imfinzi-stomach-cancer 2026-06-03T04:39:23.856Z daily 0.7 https://novapharmanews.com/us/articles/doceree-launches-daily-command-ai-platform 2026-06-03T10:58:29.832Z daily 0.7 https://novapharmanews.com/us/articles/doceree-daily-command-ai-platform 2026-06-03T04:39:45.897Z daily 0.7 https://novapharmanews.com/eu/articles/eisai-leqembi-sales-forecast 2026-06-03T04:39:43.883Z daily 0.7 https://novapharmanews.com/us/articles/trump-challenge-sen-cassidy-louisiana-primary 2026-06-03T08:36:06.190Z daily 0.7 https://novapharmanews.com/us/articles/navigating-manufacturing-challenges-biologics 2026-06-03T04:39:55.898Z daily 0.7 https://novapharmanews.com/us/articles/manufacturing-challenges-biopharma 2026-06-03T04:39:54.070Z daily 0.7 https://novapharmanews.com/eu/articles/doceree-launches-daily-command-ai-platform 2026-06-03T04:39:53.901Z daily 0.7 https://novapharmanews.com/us/articles/cder-leadership-changes-pharma-strategy 2026-06-03T06:49:24.198Z daily 0.7 https://novapharmanews.com/us/articles/pfizer-latest-developments-insights 2026-06-03T06:06:04.997Z daily 0.7 https://novapharmanews.com/us/articles/uk-advocacy-groups-challenge-pharma-trade-deal 2026-06-03T04:45:12.628Z daily 0.7 https://novapharmanews.com/us/articles/ebola-outbreak-american-exposure-congo 2026-06-03T04:40:13.926Z daily 0.7 https://novapharmanews.com/us/articles/sen-bill-cassidy-loses-primary-pharma-implications 2026-06-03T04:40:12.025Z daily 0.7 https://novapharmanews.com/apac/articles/doceree-launches-daily-command-ai-platform 2026-06-03T04:40:09.926Z daily 0.7 https://novapharmanews.com/us/articles/when-should-you-get-a-mammogram-conflicting-advice 2026-06-03T04:40:04.013Z daily 0.7 https://novapharmanews.com/apac/articles/eisai-leqembi-sales-forecast-game-changer 2026-06-03T04:40:01.926Z daily 0.7 https://novapharmanews.com/us/articles/hantavirus-outbreak-lessons-from-covid-19 2026-06-03T04:39:57.911Z daily 0.7 https://novapharmanews.com/us/articles/fda-shakeup-oncology-covid-antidepressants 2026-06-03T08:58:18.763Z daily 0.7 https://novapharmanews.com/us/articles/ebola-exposure-risk-pharma-stakeholders 2026-06-03T05:51:34.354Z daily 0.7 https://novapharmanews.com/us/articles/palvella-pivotal-data-cash-runway-rare-diseases 2026-06-03T04:40:27.943Z daily 0.7 https://novapharmanews.com/us/articles/leadership-changes-cder-cber-oncology 2026-06-03T04:40:23.929Z daily 0.7 https://novapharmanews.com/eu/articles/nice-endorses-imfinzi-stomach-cancer-regulatory-insights 2026-06-03T04:40:22.020Z daily 0.7 https://novapharmanews.com/apac/articles/kelun-biotech-new-drug-approval-skb118 2026-06-03T04:40:18.014Z daily 0.7 https://novapharmanews.com/us/articles/mammogram-guidelines-pharma-insights 2026-06-03T04:40:15.921Z daily 0.7 https://novapharmanews.com/us/articles/unlocking-value-mature-drug-products-outsourcing 2026-06-03T09:16:30.081Z daily 0.7 https://novapharmanews.com/us/articles/ebola-exposure-congo-pharma-implications 2026-06-03T06:12:29.892Z daily 0.7 https://novapharmanews.com/us/articles/navigating-manufacturing-challenges-biopharma 2026-06-03T05:57:43.574Z daily 0.7 https://novapharmanews.com/us/articles/patient-autonomy-childhood-vaccines 2026-06-03T05:20:04.211Z daily 0.7 https://novapharmanews.com/us/articles/restore-credibility-cdc-vaccine-advisory-committee 2026-06-03T05:08:44.421Z daily 0.7 https://novapharmanews.com/us/articles/biologics-manufacturing-challenges-biopharma 2026-06-03T04:40:39.961Z daily 0.7 https://novapharmanews.com/apac/articles/roches-ctdna-guided-approach-bladder-cancer 2026-06-03T04:40:37.944Z daily 0.7 https://novapharmanews.com/eu/articles/eisai-leqembi-sales-forecast-blockbuster 2026-06-03T04:40:35.960Z daily 0.7 https://novapharmanews.com/apac/articles/bms-hengrui-15b-deal-analysis 2026-06-03T04:40:29.935Z daily 0.7 https://novapharmanews.com/us/articles/compliance-data-pharma-tv-marketing 2026-06-03T11:18:58.530Z daily 0.7 https://novapharmanews.com/us/articles/pharma-brands-consumer-branding 2026-06-03T09:29:07.351Z daily 0.7 https://novapharmanews.com/us/articles/navigating-direct-to-patient-strategies-pharma 2026-06-03T08:56:16.547Z daily 0.7 https://novapharmanews.com/us/articles/ai-patient-centric-pharma-marketing 2026-06-03T05:35:44.808Z daily 0.7 https://novapharmanews.com/eu/articles/reframing-pharma-commercialization 2026-06-03T05:29:24.239Z daily 0.7 https://novapharmanews.com/us/articles/china-question-biotech-divide 2026-06-03T04:41:08.064Z daily 0.7 https://novapharmanews.com/us/articles/regeneron-immunotherapy-combo-fails-melanoma-trial 2026-06-03T04:41:06.336Z daily 0.7 https://novapharmanews.com/eu/articles/case-for-direct-to-patient-execution-challenges 2026-06-03T04:41:02.931Z daily 0.7 https://novapharmanews.com/eu/articles/why-pharma-isnt-first-voice-in-the-room 2026-06-03T04:40:55.983Z daily 0.7 https://novapharmanews.com/us/articles/ai-search-pharma-marketing 2026-06-03T04:40:49.971Z daily 0.7 https://novapharmanews.com/us/articles/manufacturing-challenges-biopharma-biologics 2026-06-03T04:40:47.973Z daily 0.7 https://novapharmanews.com/us/articles/precision-engagement-pharma-pharmaforceiq 2026-06-03T04:41:16.342Z daily 0.7 https://novapharmanews.com/eu/articles/reach-to-relevance-pharma-marketing 2026-06-03T04:41:14.336Z daily 0.7 https://novapharmanews.com/us/articles/executive-interviews-fierce-pharma-engage-2026 2026-06-03T04:41:12.340Z daily 0.7 https://novapharmanews.com/us/articles/daiichi-astrazeneca-enhertu-early-breast-cancer-approval 2026-06-03T04:41:10.326Z daily 0.7 https://novapharmanews.com/us/articles/fda-approves-astrazeneca-hypertension-drug 2026-06-03T09:33:19.207Z daily 0.7 https://novapharmanews.com/eu/articles/contact-us-for-membership 2026-06-03T07:00:24.962Z daily 0.7 https://novapharmanews.com/us/articles/us-travel-ban-ebola-affected-countries 2026-06-03T06:53:01.087Z daily 0.7 https://novapharmanews.com/us/articles/global-preparedness-hantavirus-ebola-outbreaks 2026-06-03T04:41:34.422Z daily 0.7 https://novapharmanews.com/us/articles/biopharma-ma-trends-resilience-amidst-large-deal-decline 2026-06-03T04:41:32.419Z daily 0.7 https://novapharmanews.com/us/articles/takeda-settles-kickback-allegations 2026-06-03T04:41:30.818Z daily 0.7 https://novapharmanews.com/us/articles/marty-makary-fda-misunderstanding 2026-06-03T04:41:30.415Z daily 0.7 https://novapharmanews.com/us/articles/latest-comings-and-goings-pharma-leadership 2026-06-03T04:41:28.403Z daily 0.7 https://novapharmanews.com/apac/articles/navigating-manufacturing-hurdles-biopharma 2026-06-03T04:41:26.399Z daily 0.7 https://novapharmanews.com/us/articles/ma-mid-size-pharma-deal-hunts 2026-06-03T08:07:38.615Z daily 0.7 https://novapharmanews.com/us/articles/new-ebola-outbreak-congo-2026 2026-06-03T04:41:56.461Z daily 0.7 https://novapharmanews.com/us/articles/us-pressure-germany-drug-prices-fda-upheaval 2026-06-03T04:41:54.453Z daily 0.7 https://novapharmanews.com/us/articles/cder-leadership-changes-implications-pharma 2026-06-03T04:41:52.454Z daily 0.7 https://novapharmanews.com/us/articles/supreme-court-abortion-pill-mail 2026-06-03T04:41:50.491Z daily 0.7 https://novapharmanews.com/us/articles/fda-hold-aardvark-prader-willi-drug-limbo 2026-06-03T04:41:48.444Z daily 0.7 https://novapharmanews.com/us/articles/makarys-out-at-fda-future-implications 2026-06-03T04:41:46.455Z daily 0.7 https://novapharmanews.com/us/articles/uk-political-contest-drug-pricing 2026-06-03T04:41:42.450Z daily 0.7 https://novapharmanews.com/us/articles/aardvark-next-move-clinical-hold-alumis-acelyrin 2026-06-03T04:41:40.442Z daily 0.7 https://novapharmanews.com/us/articles/asgct26-zillow-like-marketplace-abandoned-gene-therapies 2026-06-03T04:41:38.416Z daily 0.7 https://novapharmanews.com/us/articles/amgen-crackdown-340b-program-misuse 2026-06-03T04:41:36.435Z daily 0.7 https://novapharmanews.com/us/articles/supreme-court-mifepristone-mail-access 2026-06-03T08:45:58.814Z daily 0.7 https://novapharmanews.com/us/articles/trump-disloyalty-sen-cassidy-louisiana-primary 2026-06-03T08:02:35.019Z daily 0.7 https://novapharmanews.com/us/articles/stat-up-and-down-the-ladder-latest-comings-and-goings 2026-06-03T04:42:04.464Z daily 0.7 https://novapharmanews.com/us/articles/makary-resigns-biogen-alzheimers-data 2026-06-03T04:41:58.470Z daily 0.7 https://novapharmanews.com/eu/articles/oral-glp-1-tracker-wegovy-scripts-decline 2026-06-03T07:43:28.355Z daily 0.7 https://novapharmanews.com/us/articles/us-pressure-germany-drug-prices 2026-06-03T04:42:20.498Z daily 0.7 https://novapharmanews.com/us/articles/trump-blasts-sen-cassidy-louisiana-primary 2026-06-03T04:42:18.504Z daily 0.7 https://novapharmanews.com/apac/articles/scotus-restores-telehealth-access-mifepristone 2026-06-03T04:42:16.502Z daily 0.7 https://novapharmanews.com/us/articles/eisai-leqembi-sales-forecast-900m 2026-06-03T04:42:12.486Z daily 0.7 https://novapharmanews.com/us/articles/ispor-2026-international-event-coverage 2026-06-03T04:42:10.497Z daily 0.7 https://novapharmanews.com/us/articles/biopharma-ma-strength-declining-large-deals 2026-06-03T04:42:08.488Z daily 0.7 https://novapharmanews.com/apac/articles/manufacturing-challenges-biopharma 2026-06-03T04:42:06.473Z daily 0.7 https://novapharmanews.com/apac/articles/rusan-pharma-gmp-clearance-pmda 2026-06-03T07:45:00.270Z daily 0.7 https://novapharmanews.com/eu/articles/roche-elevidys-study-launch-eu-rejection 2026-06-03T05:46:46.714Z daily 0.7 https://novapharmanews.com/us/articles/political-contest-uk-drug-pricing 2026-06-03T05:20:08.777Z daily 0.7 https://novapharmanews.com/us/articles/cder-chief-hoeg-fired-fda-implications-pharma 2026-06-03T04:50:23.100Z daily 0.7 https://novapharmanews.com/us/articles/biotech-leaders-push-for-pazdur-takeda-layoffs 2026-06-03T04:42:44.521Z daily 0.7 https://novapharmanews.com/us/articles/amgen-340b-program-crackdown 2026-06-03T04:42:42.263Z daily 0.7 https://novapharmanews.com/us/articles/holland-knight-health-dose-oncology-may-12-2026 2026-06-03T04:42:38.515Z daily 0.7 https://novapharmanews.com/us/articles/takeda-settlement-kickbacks-doctors 2026-06-03T04:42:37.544Z daily 0.7 https://novapharmanews.com/eu/articles/navigating-manufacturing-challenges-biopharma 2026-06-03T04:42:32.513Z daily 0.7 https://novapharmanews.com/us/articles/indias-pharma-industry-global-compete-china 2026-06-03T04:42:26.501Z daily 0.7 https://novapharmanews.com/us/articles/us-cancer-clinics-revolution-medicines-pancreatic-cancer-drug 2026-06-03T04:42:24.495Z daily 0.7 https://novapharmanews.com/us/articles/nice-approval-imfinzi-stomach-cancer 2026-06-03T04:42:22.504Z daily 0.7 https://novapharmanews.com/us/articles/nice-backs-imfinzi-stomach-cancer 2026-06-03T04:42:49.316Z daily 0.7 https://novapharmanews.com/us/articles/understanding-fda-marty-makary-opinion 2026-06-03T04:42:46.517Z daily 0.7 https://novapharmanews.com/eu/articles/tracy-beth-hoeg-departure-fda 2026-06-03T04:42:52.576Z daily 0.7 https://novapharmanews.com/us/articles/roche-ctdna-bladder-cancer-tecentriq 2026-06-03T04:42:50.601Z daily 0.7 https://novapharmanews.com/us/articles/who-ebola-outbreak-international-emergency 2026-06-03T09:57:22.106Z daily 0.7 https://novapharmanews.com/us/articles/cloudy-truth-about-blue-zones 2026-06-03T08:03:20.842Z daily 0.7 https://novapharmanews.com/us/articles/trump-criticizes-cassidy-louisiana-primary 2026-06-03T04:42:54.592Z daily 0.7 https://novapharmanews.com/eu/articles/veeva-rd-event-preview-2026 2026-06-03T04:43:00.586Z daily 0.7 https://novapharmanews.com/us/articles/asco-2026-oncology-drug-pipeline-preview 2026-06-03T09:06:08.412Z daily 0.7 https://novapharmanews.com/us/articles/fda-eli-lilly-zepbound-obstructive-sleep-apnea-approval 2026-06-03T09:53:32.544Z daily 0.7 https://novapharmanews.com/us/articles/bio-2026-preview-companies-to-watch-key-catalysts 2026-06-03T04:43:06.609Z daily 0.7 https://novapharmanews.com/eu/articles/purdue-pharma-shutdown-opioid-settlement 2026-06-03T04:43:11.462Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-pfizer-arvinas-breast-cancer-drug-vepdegestrant 2026-06-03T04:43:10.612Z daily 0.7 https://novapharmanews.com/apac/articles/reckitt-benckiser-layoffs-new-jersey-mucinex 2026-06-03T04:43:12.706Z daily 0.7 https://novapharmanews.com/apac/articles/reckitt-benckiser-layoffs-mucinex-nj 2026-06-03T08:20:22.238Z daily 0.7 https://novapharmanews.com/apac/articles/auvelity-fda-approval-mdd-treatment 2026-06-03T04:43:16.709Z daily 0.7 https://novapharmanews.com/eu/articles/orchard-therapeutics-otl-201-innovation-passport-mps-iiia 2026-06-03T04:43:18.864Z daily 0.7 https://novapharmanews.com/us/articles/auvelity-fda-approval-mdd-treatment 2026-06-03T04:43:20.717Z daily 0.7 https://novapharmanews.com/us/articles/fda-scrutiny-post-market-data-pharma-investment-2024 2026-06-03T04:43:22.721Z daily 0.7 https://novapharmanews.com/us/articles/fda-inflation-reduction-act-pharmaceutical-pricing-2026 2026-06-03T08:42:20.453Z daily 0.7 https://novapharmanews.com/eu/articles/nice-technology-appraisals-oncology-market-access-2024 2026-06-03T10:51:57.575Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-sakigake-accelerated-approval-bispecific-antibodies-leukemia-2026 2026-06-03T06:45:19.976Z daily 0.7 https://novapharmanews.com/us/articles/anvisa-clinical-trial-changes-brazil-2024 2026-06-03T04:43:30.733Z daily 0.7 https://novapharmanews.com/us/articles/anvisa-regulatory-changes-foreign-drug-manufacturers-market-access-2024 2026-06-03T09:32:45.137Z daily 0.7 https://novapharmanews.com/us/articles/sahpra-accelerated-approval-oncology-2024 2026-06-03T04:43:34.721Z daily 0.7 https://novapharmanews.com/us/articles/ama-harmonizing-clinical-trials-impact-2024 2026-06-03T04:43:36.732Z daily 0.7 https://novapharmanews.com/us/articles/sahpra-policy-local-pharmaceutical-manufacturing-south-africa-2025 2026-06-03T08:58:13.084Z daily 0.7 https://novapharmanews.com/us/articles/fda-accelerated-approval-oncology-market-pricing-2026 2026-06-03T04:43:40.756Z daily 0.7 https://novapharmanews.com/us/articles/fda-guidance-accelerated-approval-oncology-2025 2026-06-03T06:36:08.576Z daily 0.7 https://novapharmanews.com/eu/articles/mhra-post-brexit-drug-approval-market-analysis-2026 2026-06-03T04:43:44.740Z daily 0.7 https://novapharmanews.com/eu/articles/ema-market-analysis-car-t-cell-therapy-europe-2024 2026-06-03T04:43:46.770Z daily 0.7 https://novapharmanews.com/eu/articles/ema-market-analysis-biosimilar-uptake-eu-2024 2026-06-03T04:43:48.750Z daily 0.7 https://novapharmanews.com/apac/articles/cdsco-pmda-tga-harmonization-clinical-trial-regulations-2026 2026-06-03T04:43:50.755Z daily 0.7 https://novapharmanews.com/us/articles/anvisa-approval-cannabis-framework-magictouch-2026 2026-06-03T04:43:52.762Z daily 0.7 https://novapharmanews.com/us/articles/cofepris-approval-trends-new-drug-approvals-2026 2026-06-03T04:43:54.756Z daily 0.7 https://novapharmanews.com/us/articles/anvisa-new-clinical-trial-regulations-foreign-pharma-2025 2026-06-03T04:43:56.759Z daily 0.7 https://novapharmanews.com/us/articles/anvisa-cofepris-dct-growth-latam-2024 2026-06-03T04:43:58.833Z daily 0.7 https://novapharmanews.com/us/articles/cofepris-approval-novel-immunotherapies-advanced-melanoma-2024 2026-06-03T04:44:00.757Z daily 0.7 https://novapharmanews.com/us/articles/anvisa-regulatory-changes-biosimilars-growth-brazil-2024 2026-06-03T04:44:02.852Z daily 0.7 https://novapharmanews.com/us/articles/anvisa-regulatory-changes-oncology-fast-track-approvals-2025 2026-06-03T04:44:04.774Z daily 0.7 https://novapharmanews.com/us/articles/ama-approval-cabotegravir-rilpivirine-hiv-treatment-2024 2026-06-03T04:44:06.779Z daily 0.7 https://novapharmanews.com/us/articles/moh-uae-cancer-immunotherapies-adoption-2025 2026-06-03T04:44:08.791Z daily 0.7 https://novapharmanews.com/apac/articles/purdue-pharma-shutdown-oxycontin-settlement 2026-06-03T04:44:10.782Z daily 0.7 https://novapharmanews.com/eu/articles/auvelity-fda-approval-mdd-treatment 2026-06-03T05:56:19.520Z daily 0.7 https://novapharmanews.com/us/articles/mounjaro-fda-approval-tirzepatide-eli-lilly 2026-06-03T10:05:28.359Z daily 0.7 https://novapharmanews.com/us/articles/mounjaro-fda-approval-obesity-tirzepatide-eli-lilly 2026-06-03T04:44:16.793Z daily 0.7 https://novapharmanews.com/us/articles/osimertinib-fda-approval-early-stage-nsclc 2026-06-03T04:44:18.786Z daily 0.7 https://novapharmanews.com/us/articles/ama-regulatory-harmonization-pharmaceutical-market-access-2026 2026-06-03T04:44:20.797Z daily 0.7 https://novapharmanews.com/apac/articles/nmpa-accelerated-approval-pathway-innovative-drug-market-entry-2024 2026-06-03T04:44:22.792Z daily 0.7 https://novapharmanews.com/apac/articles/nmpa-approval-pd1-pdl1-lung-cancer-immunotherapy-2025 2026-06-03T04:44:24.795Z daily 0.7 https://novapharmanews.com/apac/articles/nmpa-conditional-approval-pathway-oncology-access-2024 2026-06-03T04:44:26.795Z daily 0.7 https://novapharmanews.com/eu/articles/ema-eu-pharmaceutical-legislation-reform-orphan-drug-market-exclusivity-2026 2026-06-03T05:34:26.734Z daily 0.7 https://novapharmanews.com/eu/articles/ema-market-analysis-antibody-drug-conjugates-breast-cancer-2025 2026-06-03T08:25:38.162Z daily 0.7 https://novapharmanews.com/eu/articles/ema-conditional-marketing-authorization-linvoseltamab-rrmm-2025 2026-06-03T04:44:32.813Z daily 0.7 https://novapharmanews.com/eu/articles/ema-eu-clinical-trials-regulation-impact-rare-disease-2024 2026-06-03T04:44:34.824Z daily 0.7 https://novapharmanews.com/us/articles/fda-market-analysis-bispecific-antibodies-hematological-malignancies-2024 2026-06-03T07:19:29.776Z daily 0.7 https://novapharmanews.com/us/articles/fda-analysis-semaglutide-posdinemab-alzheimers-failures-2025 2026-06-03T09:36:38.477Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-oncoblast-market-impact-advanced-melanoma 2026-06-03T04:44:40.828Z daily 0.7 https://novapharmanews.com/apac/articles/ama-implementation-regulatory-harmonization-pharmaceutical-market-access-2026 2026-06-03T04:44:42.836Z daily 0.7 https://novapharmanews.com/apac/articles/nmepa-priority-review-pathway-innovative-drug-approvals-2024 2026-06-03T06:19:47.213Z daily 0.7 https://novapharmanews.com/eu/articles/ema-eu-pharmaceutical-legislation-reform-generic-biosimilar-market-2026 2026-06-03T09:28:32.798Z daily 0.7 https://novapharmanews.com/eu/articles/ema-approval-teclistamab-elranatamab-multiple-myeloma-2024 2026-06-03T06:06:54.665Z daily 0.7 https://novapharmanews.com/eu/articles/ema-conditional-approval-car-t-relapsed-b-cell-lymphomas-2024 2026-06-03T04:44:50.838Z daily 0.7 https://novapharmanews.com/eu/articles/ema-conditional-approval-repotrectinib-oncology-patient-access-2026 2026-06-03T04:44:52.832Z daily 0.7 https://novapharmanews.com/us/articles/fda-accelerated-approval-zongertinib-oncology-2026 2026-06-03T04:44:54.853Z daily 0.7 https://novapharmanews.com/us/articles/fda-market-analysis-kras-g12c-inhibitors-nsclc-2024 2026-06-03T04:45:01.389Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-elranatamab-rrmm-2023 2026-06-03T04:44:58.849Z daily 0.7 https://novapharmanews.com/us/articles/fda-analysis-car-t-therapy-clinical-trials-asco-2026 2026-06-03T11:00:35.298Z daily 0.7 https://novapharmanews.com/us/articles/fda-guidance-decentralized-clinical-trials-2024 2026-06-03T10:57:13.924Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-elarekig-treatment-resistant-depression-2026 2026-06-03T04:45:04.851Z daily 0.7 https://novapharmanews.com/eu/articles/g-ba-nice-hta-outcomes-oncology-therapies-2025 2026-06-03T10:49:03.040Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-regulatory-update-biosimilar-landscape-japan-2024 2026-06-03T10:35:44.477Z daily 0.7 https://novapharmanews.com/apac/articles/nmepa-data-integrity-requirements-foreign-pharma-apac-2024 2026-06-03T10:30:01.972Z daily 0.7 https://novapharmanews.com/us/articles/fda-accelerated-approval-oncology-evolving-pathways-2026 2026-06-03T10:27:14.837Z daily 0.7 https://novapharmanews.com/apac/articles/nmpa-reforms-china-clinical-trial-regulations-2024 2026-06-03T10:14:05.073Z daily 0.7 https://novapharmanews.com/apac/articles/nmpa-acceptance-foreign-clinical-trial-data-impact-2024 2026-06-03T10:06:40.688Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-biosimilar-regulation-japan-2024-analysis 2026-06-03T09:37:55.372Z daily 0.7 https://novapharmanews.com/eu/articles/ema-hta-regulation-impact-rare-disease-drug-approval-2026 2026-06-03T08:39:58.028Z daily 0.7 https://novapharmanews.com/apac/articles/nmpa-data-integrity-foreign-pharma-impact-2026 2026-06-03T08:32:01.946Z daily 0.7 https://novapharmanews.com/us/articles/fda-accelerated-approval-pathway-oncology-market-access-2026 2026-06-03T08:28:59.222Z daily 0.7 https://novapharmanews.com/us/articles/sfda-expedited-drug-approval-saudi-pharmaceutical-market-2024 2026-06-03T08:26:28.191Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-approval-biosimilar-market-growth-japan-2024 2026-06-03T07:58:34.059Z daily 0.7 https://novapharmanews.com/us/articles/fda-inflation-reduction-act-drug-pricing-negotiations-2026 2026-06-03T07:45:38.233Z daily 0.7 https://novapharmanews.com/us/articles/fda-accelerated-approval-oncology-benefit-risk-2026 2026-06-03T06:49:59.057Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-regulatory-update-biosimilars-market-analysis-2024 2026-06-03T06:15:20.499Z daily 0.7 https://novapharmanews.com/eu/articles/ema-eu-clinical-trial-ethics-committees-analysis-2024 2026-06-03T05:04:35.770Z daily 0.7 https://novapharmanews.com/eu/articles/ema-biosimilar-oncology-antibodies-market-impact-2024 2026-06-03T04:46:24.990Z daily 0.7 https://novapharmanews.com/eu/articles/ema-mhra-real-world-evidence-oncology-2024 2026-06-03T04:46:22.991Z daily 0.7 https://novapharmanews.com/eu/articles/ema-market-analysis-biosimilars-growth-eu-2024 2026-06-03T04:46:16.977Z daily 0.7 https://novapharmanews.com/apac/articles/nmepa-data-integrity-foreign-pharma-approval-2024 2026-06-03T04:46:14.972Z daily 0.7 https://novapharmanews.com/eu/articles/ema-pediatric-investigation-plans-oncology-2024 2026-06-03T04:46:12.984Z daily 0.7 https://novapharmanews.com/us/articles/fda-validation-framework-ai-oncology-drug-development-2025 2026-06-03T04:46:08.986Z daily 0.7 https://novapharmanews.com/eu/articles/ema-hta-outcomes-oncology-drugs-eu-regulation-2024 2026-06-03T04:46:06.976Z daily 0.7 https://novapharmanews.com/us/articles/fda-adagrasib-phase3-trial-results-kras-g12c-nsclc-2024 2026-06-03T04:46:04.977Z daily 0.7 https://novapharmanews.com/apac/articles/nmra-clinical-trial-quality-management-apac-2024 2026-06-03T04:46:02.971Z daily 0.7 https://novapharmanews.com/eu/articles/ema-conditional-marketing-authorizations-oncology-2025 2026-06-03T04:46:00.962Z daily 0.7 https://novapharmanews.com/eu/articles/ema-regulatory-framework-european-biomarker-driven-trials-2024 2026-06-03T04:45:58.971Z daily 0.7 https://novapharmanews.com/us/articles/fda-phase2-failure-posdinemab-alzheimers-market-analysis-2025 2026-06-03T04:45:56.975Z daily 0.7 https://novapharmanews.com/us/articles/fda-analysis-novo-nordisk-semaglutide-alzheimers-failure-2025 2026-06-03T04:45:54.955Z daily 0.7 https://novapharmanews.com/us/articles/fda-market-analysis-alzheimers-clinical-trial-failures-2024 2026-06-03T04:45:50.959Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-elarekibart-treatment-resistant-hypertension-2026 2026-06-03T04:45:47.053Z daily 0.7 https://novapharmanews.com/eu/articles/ema-clinical-trial-site-selection-qualification-requirements-2024 2026-06-03T04:45:42.941Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-biosimilars-market-analysis-2026 2026-06-03T04:45:34.933Z daily 0.7 https://novapharmanews.com/eu/articles/ema-approval-novel-immunotherapies-advanced-melanoma-2026 2026-06-03T04:45:34.509Z daily 0.7 https://novapharmanews.com/us/articles/fda-market-analysis-biosimilars-us-inflation-reduction-act-2026 2026-06-03T04:45:33.607Z daily 0.7 https://novapharmanews.com/us/articles/fda-biosimilars-approval-market-analysis-2026 2026-06-03T04:45:30.877Z daily 0.7 https://novapharmanews.com/us/articles/fda-companion-diagnostic-policies-precision-oncology-2025 2026-06-03T04:45:18.883Z daily 0.7 https://novapharmanews.com/us/articles/sfda-accelerated-approval-anktiva-oncology-impact-2024 2026-06-03T04:45:16.867Z daily 0.7 https://novapharmanews.com/us/articles/fda-accelerated-approval-reforms-oncology-market-access-2026 2026-06-03T04:45:10.863Z daily 0.7 https://novapharmanews.com/apac/articles/nmepa-data-integrity-foreign-pharma-compliance-2026 2026-06-03T04:45:06.852Z daily 0.7 https://novapharmanews.com/us/articles/ama-progress-harmonizing-regulatory-standards-africa-2024 2026-06-03T04:46:26.999Z daily 0.7 https://novapharmanews.com/eu/articles/ema-eu-pharmaceutical-legislation-reform-orphan-drug-2026 2026-06-03T04:46:29.004Z daily 0.7 https://novapharmanews.com/eu/articles/ema-conditional-approval-car-t-b-cell-lymphomas-2024 2026-06-03T04:46:31.017Z daily 0.7 https://novapharmanews.com/us/articles/fda-biosimilar-approval-pathway-regulatory-changes-2026 2026-06-03T07:21:13.570Z daily 0.7 https://novapharmanews.com/us/articles/fda-market-analysis-teclistamab-bispecific-antibody-therapies-rrmm-2025 2026-06-03T04:46:35.016Z daily 0.7 https://novapharmanews.com/us/articles/fda-analysis-tirzepatide-surpass-cvot-cardiovascular-safety-2024 2026-06-03T10:29:21.669Z daily 0.7 https://novapharmanews.com/eu/articles/ema-impact-revised-eu-pharmaceutical-legislation-orphan-drug-2026 2026-06-03T09:53:05.366Z daily 0.7 https://novapharmanews.com/eu/articles/ema-conditional-approval-repotrectinib-oncology-2026 2026-06-03T04:46:41.018Z daily 0.7 https://novapharmanews.com/us/articles/fda-market-analysis-bispecific-antibodies-hematological-malignancies-2025 2026-06-03T07:19:29.605Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-pembrolizumab-msi-high-solid-tumors-2024 2026-06-03T11:22:47.761Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-revnasiran-market-analysis-2024 2026-06-03T04:46:47.082Z daily 0.7 https://novapharmanews.com/apac/articles/pfizer-ai-strategy-pharma-innovation-dominance 2026-06-03T06:28:15.953Z daily 0.7 https://novapharmanews.com/apac/articles/ai-drug-discovery-patent-rankings-2025-deep-eigenmatics-leads 2026-06-03T06:19:19.998Z daily 0.7 https://novapharmanews.com/apac/articles/ai-driven-drug-discovery-partnership-merck-mayo-clinic 2026-06-03T04:46:53.089Z daily 0.7 https://novapharmanews.com/apac/articles/pharma-supercomputer-eli-lilly-nvidia-ai-drug-discovery 2026-06-03T11:18:54.082Z daily 0.7 https://novapharmanews.com/apac/articles/merck-mayo-clinic-ai-partnership-drug-discovery 2026-06-03T04:46:57.095Z daily 0.7 https://novapharmanews.com/us/articles/sahpra-serialization-cancer-drug-supply-security-2024 2026-06-03T06:04:08.640Z daily 0.7 https://novapharmanews.com/us/articles/ama-implementation-regulatory-harmonization-pharma-access-2026 2026-06-03T04:53:33.495Z daily 0.7 https://novapharmanews.com/eu/articles/automation-eco-friendly-pharma-packaging 2026-06-03T04:47:09.376Z daily 0.7 https://novapharmanews.com/apac/articles/nmpa-approval-adcs-lung-cancer-trends-2025 2026-06-03T07:58:52.166Z daily 0.7 https://novapharmanews.com/eu/articles/ema-hta-trastuzumab-deruxtecan-eu-market-access-2025 2026-06-03T04:47:07.120Z daily 0.7 https://novapharmanews.com/us/articles/fda-breakthrough-therapy-designations-neurological-disorders-market-analysis-2026 2026-06-03T10:20:18.655Z daily 0.7 https://novapharmanews.com/us/articles/fda-market-analysis-bispecific-antibody-therapies-b-cell-lymphomas-2024 2026-06-03T04:47:11.123Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-pembrolizumab-expanded-use-keynote-826-2024 2026-06-03T09:49:24.774Z daily 0.7 https://novapharmanews.com/us/articles/fda-accelerated-approval-zongertinib-oncology-market-analysis-2026 2026-06-03T04:47:15.121Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-elarekibart-ailectra-attr-amyloidosis-2026 2026-06-03T04:47:17.145Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-regulatory-pathways-car-t-cell-therapy-japan-2024 2026-06-03T10:59:08.275Z daily 0.7 https://novapharmanews.com/us/articles/fda-labeling-changes-oral-semaglutide-cardiovascular-risk-2025 2026-06-03T04:47:21.144Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-sotorasib-adagrasib-kras-g12c-nsclc-2024 2026-06-03T09:24:20.705Z daily 0.7 https://novapharmanews.com/us/articles/fda-phase3-results-ensartinib-alk-nsclc-2024 2026-06-03T04:47:25.141Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-pembrolizumab-label-expansion-advanced-cervical-cancer-2024 2026-06-03T06:07:27.849Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-mresvia-mrna-vaccine-rsv-market-analysis-2024 2026-06-03T04:47:29.147Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-guideline-update-biosimilar-landscape-japan-2025 2026-06-03T04:49:59.259Z daily 0.7 https://novapharmanews.com/eu/articles/ema-eu-pharmaceutical-legislation-reform-biosimilar-market-access-2025 2026-06-03T04:47:33.159Z daily 0.7 https://novapharmanews.com/eu/articles/ema-eu-pharmaceutical-legislation-reform-generics-biosimilars-2026 2026-06-03T04:47:35.146Z daily 0.7 https://novapharmanews.com/eu/articles/ema-cross-border-healthcare-car-t-access-eu-policy-2024 2026-06-03T04:47:37.149Z daily 0.7 https://novapharmanews.com/us/articles/fda-accelerated-approval-kras-g12c-inhibitors-nsclc-2024 2026-06-03T09:53:00.614Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-pembrolizumab-expanded-label-advanced-cervical-cancer-2024 2026-06-03T04:47:41.157Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-vx-009-oncodex-oncolytic-virus-therapy-2026 2026-06-03T04:47:43.172Z daily 0.7 https://novapharmanews.com/apac/articles/nmpa-accelerated-approval-oncology-innovative-drugs-2024 2026-06-03T04:47:45.269Z daily 0.7 https://novapharmanews.com/eu/articles/ema-implementation-clinical-trial-data-sharing-2024 2026-06-03T04:47:47.181Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-resvax-rsv-vaccine-market-analysis-2024 2026-06-03T09:34:14.794Z daily 0.7 https://novapharmanews.com/us/articles/sahpra-biosimilars-approval-pathway-analysis-2025 2026-06-03T04:47:51.185Z daily 0.7 https://novapharmanews.com/us/articles/ama-impact-regulatory-harmonization-drug-access-2024 2026-06-03T04:47:53.175Z daily 0.7 https://novapharmanews.com/eu/articles/ema-safety-monitoring-phase-1-trial-evolution-2024 2026-06-03T09:20:34.103Z daily 0.7 https://novapharmanews.com/eu/articles/ema-guidelines-treatment-sequencing-advanced-nsclc-2024 2026-06-03T04:47:57.175Z daily 0.7 https://novapharmanews.com/eu/articles/ema-framework-cell-therapy-manufacturing-car-t-availability-2025 2026-06-03T04:47:59.176Z daily 0.7 https://novapharmanews.com/eu/articles/ema-revised-eu-pharmaceutical-legislation-biosimilar-market-entry-2027 2026-06-03T04:48:01.177Z daily 0.7 https://novapharmanews.com/eu/articles/ema-eu-pharmaceutical-legislation-reform-orphan-drugs-2025 2026-06-03T09:53:05.255Z daily 0.7 https://novapharmanews.com/us/articles/fda-guidance-accelerated-approval-oncology-postmarket-2025 2026-06-03T10:03:00.272Z daily 0.7 https://novapharmanews.com/us/articles/fda-pipeline-analysis-next-generation-immunotherapy-2024 2026-06-03T05:07:10.792Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-sakigake-designation-expedited-drug-development-2026 2026-06-03T11:04:35.834Z daily 0.7 https://novapharmanews.com/us/articles/cofepris-approval-trends-new-drugs-2026 2026-06-03T04:48:11.198Z daily 0.7 https://novapharmanews.com/us/articles/fda-guidance-clinical-trial-transparency-results-reporting-2026 2026-06-03T06:07:14.362Z daily 0.7 https://novapharmanews.com/us/articles/nafdac-new-requirements-pediatric-clinical-trials-2024 2026-06-03T04:48:17.689Z daily 0.7 https://novapharmanews.com/us/articles/sahpra-next-generation-sequencing-precision-oncology-mea-2024 2026-06-03T04:48:17.207Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-regulatory-update-biosimilar-market-growth-japan-2024 2026-06-03T04:48:19.203Z daily 0.7 https://novapharmanews.com/us/articles/fda-breakthrough-therapy-designation-rare-disease-market-analysis-2024 2026-06-03T04:48:21.202Z daily 0.7 https://novapharmanews.com/us/articles/fda-update-patritumab-deruxtecan-brain-metastasis-therapy-2024 2026-06-03T04:48:23.211Z daily 0.7 https://novapharmanews.com/us/articles/fda-updated-requirements-pediatric-clinical-trials-2024 2026-06-03T09:16:20.469Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-elarekig-treatment-resistant-depression-2024 2026-06-03T04:48:27.210Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-viruxa-oncolytic-virus-therapy-advanced-melanoma-2026 2026-06-03T04:48:29.218Z daily 0.7 https://novapharmanews.com/us/articles/fda-guidance-accelerated-approval-oncology-2024 2026-06-03T06:56:18.492Z daily 0.7 https://novapharmanews.com/us/articles/fda-evolving-rwe-framework-drug-approvals-2025 2026-06-03T07:00:09.184Z daily 0.7 https://novapharmanews.com/eu/articles/ema-fda-comparative-analysis-clinical-trial-protocols-2024 2026-06-03T04:48:39.092Z daily 0.7 https://novapharmanews.com/eu/articles/ema-market-access-egfr-inhibitors-launch-strategies-2024 2026-06-03T04:48:37.241Z daily 0.7 https://novapharmanews.com/eu/articles/ema-nice-gba-oncology-drug-market-analysis-2026 2026-06-03T04:48:39.250Z daily 0.7 https://novapharmanews.com/apac/articles/nmpa-integration-chinese-adcs-clinical-practice-2024 2026-06-03T04:48:41.237Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-regulatory-updates-biosimilar-landscape-japan-2025 2026-06-03T07:56:23.322Z daily 0.7 https://novapharmanews.com/us/articles/cofepris-approval-trends-fast-track-generics-2026 2026-06-03T04:48:45.281Z daily 0.7 https://novapharmanews.com/us/articles/anvisa-biomarker-testing-brazil-oncology-market-2024 2026-06-03T04:48:47.247Z daily 0.7 https://novapharmanews.com/us/articles/pandrh-regulatory-harmonization-biosimilar-market-entry-latam-2026 2026-06-03T04:48:52.429Z daily 0.7 https://novapharmanews.com/us/articles/sfda-accelerated-approval-oncology-drugs-2024 2026-06-03T04:48:51.249Z daily 0.7 https://novapharmanews.com/us/articles/ppb-new-guidelines-research-site-certification-kenya-2026 2026-06-03T04:48:53.443Z daily 0.7 https://novapharmanews.com/us/articles/gcc-drug-guidelines-oncology-treatment-standardization-2024 2026-06-03T04:48:55.252Z daily 0.7 https://novapharmanews.com/us/articles/sfda-accelerated-drug-approval-saudi-pharmaceutical-market-2024 2026-06-03T11:03:25.622Z daily 0.7 https://novapharmanews.com/us/articles/gcc-dr-harmonization-pharmaceutical-market-access-2024 2026-06-03T11:19:36.587Z daily 0.7 https://novapharmanews.com/apac/articles/nmpa-elisrasib-apac-kras-inhibitors-2024 2026-06-03T04:49:01.259Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-sakigake-designation-cardiovascular-drug-approval-2024 2026-06-03T04:49:03.366Z daily 0.7 https://novapharmanews.com/eu/articles/ema-prac-safety-signal-bispecific-antibodies-hematologic-malignancies-2025 2026-06-03T04:49:05.263Z daily 0.7 https://novapharmanews.com/us/articles/fda-market-report-small-molecule-vs-biologics-oncology-2024 2026-06-03T04:49:07.267Z daily 0.7 https://novapharmanews.com/us/articles/fda-accelerated-approval-oncology-impact-2024 2026-06-03T04:49:09.271Z daily 0.7 https://novapharmanews.com/us/articles/fda-clinical-trial-protocol-amendments-impact-2024 2026-06-03T04:49:12.293Z daily 0.7 https://novapharmanews.com/us/articles/fda-cid-pilot-program-complex-innovative-trial-designs-2024 2026-06-03T04:49:13.460Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-elarekibart-xylantra-treatment-resistant-hypertension-2024 2026-06-03T08:10:18.905Z daily 0.7 https://novapharmanews.com/us/articles/fda-evolving-continuous-manufacturing-drug-quality-2024 2026-06-03T09:14:47.513Z daily 0.7 https://novapharmanews.com/eu/articles/ema-analysis-continuous-manufacturing-pharmaceuticals-2024 2026-06-03T04:49:19.370Z daily 0.7 https://novapharmanews.com/us/articles/fda-inflation-reduction-act-pharmaceutical-pricing-2024 2026-06-03T10:35:54.893Z daily 0.7 https://novapharmanews.com/us/articles/fda-evolving-stance-rwe-drug-development-2024 2026-06-03T04:49:23.299Z daily 0.7 https://novapharmanews.com/us/articles/fda-guidance-diversity-clinical-trials-2024 2026-06-03T04:49:25.302Z daily 0.7 https://novapharmanews.com/us/articles/fda-project-frontrunner-initiative-oncology-drug-reviews-2024 2026-06-03T06:36:08.676Z daily 0.7 https://novapharmanews.com/us/articles/fda-accelerated-approval-oncology-trends-2026 2026-06-03T08:22:05.971Z daily 0.7 https://novapharmanews.com/us/articles/fda-guidelines-clinical-trial-site-selection-2025 2026-06-03T04:49:31.334Z daily 0.7 https://novapharmanews.com/us/articles/fda-commercial-analysis-us-oncology-biosimilar-landscape-2026 2026-06-03T04:49:39.414Z daily 0.7 https://novapharmanews.com/us/articles/fda-accelerated-approval-oncology-market-access-2026 2026-06-03T04:49:35.301Z daily 0.7 https://novapharmanews.com/us/articles/fda-biosimilars-patent-expirations-market-analysis-2026 2026-06-03T06:34:42.340Z daily 0.7 https://novapharmanews.com/eu/articles/ema-analysis-european-academic-clinical-trials-funding-success-2024-2026 2026-06-03T04:49:39.312Z daily 0.7 https://novapharmanews.com/us/articles/anvisa-approval-drugname-indication-market-analysis-2025 2026-06-03T04:49:41.312Z daily 0.7 https://novapharmanews.com/us/articles/anvisa-guidelines-antibody-drug-conjugates-oncology-2025 2026-06-03T04:49:43.322Z daily 0.7 https://novapharmanews.com/us/articles/moh-uae-dubai-science-park-phase1-studies-2024 2026-06-03T04:49:45.332Z daily 0.7 https://novapharmanews.com/us/articles/sahpra-accelerated-review-novel-cancer-therapies-2024 2026-06-03T04:49:47.317Z daily 0.7 https://novapharmanews.com/us/articles/sahpra-antibody-drug-conjugates-pricing-access-mea-2024 2026-06-03T04:49:49.323Z daily 0.7 https://novapharmanews.com/us/articles/sfda-accelerated-drug-approval-saudi-pharma-market-2024 2026-06-03T04:49:51.326Z daily 0.7 https://novapharmanews.com/us/articles/ama-progress-harmonizing-drug-regulation-africa-2024 2026-06-03T04:49:53.329Z daily 0.7 https://novapharmanews.com/apac/articles/market-access-nmpa-177lu-psma-617-prostate-cancer-2024 2026-06-03T04:49:55.331Z daily 0.7 https://novapharmanews.com/eu/articles/nice-technology-appraisals-market-access-eu-2026 2026-06-03T04:50:02.853Z daily 0.7 https://novapharmanews.com/eu/articles/mhra-post-brexit-drug-approval-oncology-divergences-2024 2026-06-03T04:50:05.904Z daily 0.7 https://novapharmanews.com/us/articles/african-medicines-agency-impact-regulatory-harmonization-2024 2026-06-03T04:50:01.349Z daily 0.7 https://novapharmanews.com/us/articles/sahpra-approval-lenacapavir-hiv-treatment-2025 2026-06-03T07:30:57.329Z daily 0.7 https://novapharmanews.com/us/articles/cofepris-biocomparables-pathway-biosimilars-mexico-2025 2026-06-03T07:56:40.110Z daily 0.7 https://novapharmanews.com/apac/articles/nmepa-priority-review-innovative-drug-approvals-2024 2026-06-03T04:50:07.573Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-regulatory-updates-sakigake-biosimilar-landscape-japan-2024 2026-06-03T04:50:09.524Z daily 0.7 https://novapharmanews.com/eu/articles/ema-eu-pharmaceutical-legislation-reform-generic-biosimilar-2026-27 2026-06-03T04:50:11.532Z daily 0.7 https://novapharmanews.com/eu/articles/ema-accelerated-assessment-oncology-approval-timelines-2024 2026-06-03T04:50:20.389Z daily 0.7 https://novapharmanews.com/eu/articles/ema-conditional-approval-linvoseltamab-oncology-2026 2026-06-03T07:40:08.464Z daily 0.7 https://novapharmanews.com/us/articles/fda-safety-labeling-antidepressant-market-analysis-2026 2026-06-03T04:50:17.539Z daily 0.7 https://novapharmanews.com/us/articles/fda-accelerated-approval-zongertinib-oncology-policy-2026 2026-06-03T09:42:23.964Z daily 0.7 https://novapharmanews.com/us/articles/african-medicines-agency-impact-multi-regional-clinical-trials-2025 2026-06-03T04:50:21.656Z daily 0.7 https://novapharmanews.com/us/articles/moh-uae-cancer-clinical-trials-hub-2024 2026-06-03T04:50:25.390Z daily 0.7 https://novapharmanews.com/us/articles/eda-local-manufacturing-generic-oncology-egypt-2024 2026-06-03T04:50:25.646Z daily 0.7 https://novapharmanews.com/us/articles/sahpra-approval-lenacapavir-hiv-prevention-2025 2026-06-03T04:50:27.632Z daily 0.7 https://novapharmanews.com/apac/articles/tga-innovation-australian-biotech-solid-tumor-car-t-2024 2026-06-03T04:50:29.648Z daily 0.7 https://novapharmanews.com/us/articles/anvisa-rebec-clinical-trial-registry-analysis-2024 2026-06-03T10:39:35.771Z daily 0.7 https://novapharmanews.com/eu/articles/ema-hta-car-t-therapies-cost-effectiveness-2024 2026-06-03T09:05:25.082Z daily 0.7 https://novapharmanews.com/eu/articles/mhra-post-brexit-regulatory-pathways-divergence-2024 2026-06-03T09:09:59.032Z daily 0.7 https://novapharmanews.com/us/articles/fda-breakthrough-therapy-designations-neurological-disorders-2026 2026-06-03T06:37:38.265Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-sotatercept-winrevair-pah-market-analysis-2024 2026-06-03T10:08:59.942Z daily 0.7 https://novapharmanews.com/us/articles/fda-clinical-trial-cost-analysis-phase1-3-2024 2026-06-03T10:16:46.613Z daily 0.7 https://novapharmanews.com/us/articles/cms-medicare-coverage-expansion-car-t-therapies-2024 2026-06-03T04:50:50.910Z daily 0.7 https://novapharmanews.com/eu/articles/ema-framework-real-world-evidence-hybrid-trial-designs-2024 2026-06-03T04:50:45.655Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-updated-biosimilar-interchangeability-guidelines-2024 2026-06-03T04:50:47.651Z daily 0.7 https://novapharmanews.com/eu/articles/ema-proposed-pharmaceutical-legislation-reform-orphan-drug-2024 2026-06-03T07:08:17.425Z daily 0.7 https://novapharmanews.com/apac/articles/nmpa-approval-accelerated-conditional-oncology-2024 2026-06-03T09:22:57.571Z daily 0.7 https://novapharmanews.com/apac/articles/hsa-clinical-trial-modernization-citds-2024 2026-06-03T04:50:53.662Z daily 0.7 https://novapharmanews.com/us/articles/fda-accelerated-approval-oncology-policy-changes-2026 2026-06-03T04:50:55.658Z daily 0.7 https://novapharmanews.com/apac/articles/nmpa-accelerated-approval-innovative-drug-market-entry-2024 2026-06-03T09:59:48.305Z daily 0.7 https://novapharmanews.com/eu/articles/ema-hta-radioligand-therapy-prostate-cancer-2024 2026-06-03T04:50:59.662Z daily 0.7 https://novapharmanews.com/eu/articles/ema-chmp-positive-opinions-diabetes-drugs-q3-2026 2026-06-03T06:50:00.285Z daily 0.7 https://novapharmanews.com/us/articles/fda-phase3-data-checkpoint-inhibitor-combinations-melanoma-2024 2026-06-03T04:51:03.675Z daily 0.7 https://novapharmanews.com/eu/articles/ema-decision-biosimilar-pricing-oncology-2024 2026-06-03T04:51:05.666Z daily 0.7 https://novapharmanews.com/us/articles/fda-biosimilar-competition-impact-us-biologics-2026 2026-06-03T04:51:07.674Z daily 0.7 https://novapharmanews.com/eu/articles/ema-prac-guidelines-drug-induced-liver-injury-2024 2026-06-03T05:48:37.945Z daily 0.7 https://novapharmanews.com/apac/articles/nmpla-expedited-approval-oncology-patient-access-2024 2026-06-03T06:19:07.559Z daily 0.7 https://novapharmanews.com/eu/articles/ema-comp-ai-rare-disease-drug-discovery-2024 2026-06-03T04:51:13.685Z daily 0.7 https://novapharmanews.com/us/articles/fda-telemedicine-pharmaceutical-access-adherence-2024 2026-06-03T04:51:15.696Z daily 0.7 https://novapharmanews.com/eu/articles/ema-integration-rwe-ehrs-regulatory-decisions-2024 2026-06-03T04:51:17.699Z daily 0.7 https://novapharmanews.com/apac/articles/pmda-ai-drug-discovery-development-japan-2024 2026-06-03T09:34:01.016Z daily 0.7 https://novapharmanews.com/us/articles/fda-action-digital-health-innovation-samd-2024 2026-06-03T04:51:21.696Z daily 0.7 https://novapharmanews.com/us/articles/fda-ai-accelerating-drug-approvals-2024 2026-06-03T04:51:23.699Z daily 0.7 https://novapharmanews.com/us/articles/fda-blockchain-pharmaceutical-supply-chain-2024 2026-06-03T08:22:49.143Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-enzyme-replacement-therapy-gaucher-2024 2026-06-03T04:51:27.701Z daily 0.7 https://novapharmanews.com/us/articles/fda-market-analysis-gene-therapies-sma-2024 2026-06-03T04:51:29.696Z daily 0.7 https://novapharmanews.com/us/articles/fda-regulatory-pathways-car-t-cell-therapy-advancements-2024 2026-06-03T10:21:56.761Z daily 0.7 https://novapharmanews.com/us/articles/fda-approval-gene-therapies-hemophilia-market-analysis-2024 2026-06-03T04:51:36.837Z daily 0.7 https://novapharmanews.com/us/articles/fda-breakthrough-therapy-designations-alzheimers-2024 2026-06-03T04:51:35.700Z daily 0.7 https://novapharmanews.com/us/articles/fda-master-protocols-platform-trials-development-2024 2026-06-03T04:51:39.154Z daily 0.7 https://novapharmanews.com/us/articles/fda-approved-kras-inhibitors-lung-cancer-2024 2026-06-03T04:51:39.710Z daily 0.7